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Lysosomal membrane permeabilization (LMP) and cathepsin release typiﬁes lysosomedependent cell death (LDCD). However, LMP occurs in most regulated cell death programs
suggesting LDCD is not an independent cell death pathway, but is conscripted to facilitate the
ﬁnal cellular demise by other cell death routines. Previously, we demonstrated that Caenorhabditis elegans (C. elegans) null for a cysteine protease inhibitor, srp-6, undergo a speciﬁc
LDCD pathway characterized by LMP and cathepsin-dependent cytoplasmic proteolysis. We
designated this cell death routine, lysoptosis, to distinguish it from other pathways employing
LMP. In this study, mouse and human epithelial cells lacking srp-6 homologues, mSerpinb3a
and SERPINB3, respectively, demonstrated a lysoptosis phenotype distinct from other cell
death pathways. Like in C. elegans, this pathway depended on LMP and released cathepsins,
predominantly cathepsin L. These studies suggested that lysoptosis is an evolutionarilyconserved eukaryotic LDCD that predominates in the absence of neutralizing endogenous
inhibitors.
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ince Christian De Duve’s discovery of lysosomes in 1955, it
has been debated whether lysosomal membrane permeabilization (LMP) compromises cell survival, or heralds the
onset of postmortem autolysis. Nonetheless, lysosome-dependent
cell death (LDCD) is one of a dozen regulated cell death (RCD)
subroutines identiﬁed by the Nomenclature Committee on Cell
Death1. LDCD is deﬁned by the presence of lysosomal membrane
permeabilization (LMP) followed by the release of cathepsins into
the cytosol2. While LDCD has a discernable role in a few physiological processes; its contribution to other pathological stressors is incompletely understood3–6.
The role of lysosomes and LMP in mammalian cell death
pathways has been difﬁcult to ascertain. LMP and cathepsin
release are detected in most cell death routines including
apoptosis1,7, mitochondrial permeability transition-driven
necrosis (MPT-DN)8,9, ferroptosis10, pyroptosis11, and
necroptosis12–14. Moreover, morphology cannot always be used
to determine the role of LMP in RCD15, as cells dying by LDCD
can exhibit both apoptotic1,2,16,17 and necrotic morphological
hallmarks18–23. Additionally, extracellular and intracellular
stressors activate signaling pathways that are interconnected and
molecular crosstalk simultaneously activates several pro-death
and/or pro-survival pathways1,2,24. Therefore, molecular events
contributing to LDCD could simultaneously trigger parallel death
signaling cascades making it difﬁcult to discern which pathway
served as the principal executioner. Furthermore, the lysosomal
cysteine proteases are highly processive with broad substrate
speciﬁcity25. Cytosolic cathepsins can destroy evidence of preexisting cell death routines by degrading signaling molecules
associated with different forms of RCD25–28. The prevalence of
these associations brings into question whether LDCD serves as a
primary or stand-alone RCD pathway or is an epiphenomenon
associated with the terminal stages of all cell deaths.
Although it has been difﬁcult to establish the contribution of
LDCD or LMP within the hierarchy of RCD pathways in mammalian systems11,17,28–31, simpler model organisms have been
instrumental in deﬁning the core components of cell death
routines32–34. In particular, C. elegans also undergoes several
different forms of LDCD independent of caspase activation35,36.
Neurons expressing a gain-of-function mutation in one of several
different types of ion channels undergo a form of excitotoxic cell
death with a necrotic phenotype37–40. In a different C. elegans
model of LDCD, we discovered that animals null for the intracellular serine/cysteine protease inhibitor (serpin), srp-6, an
inhibitor of calpains and lysosomal cysteine cathepsins, are sensitized to intestinal cell necrosis leading to organismal death41.
Several exogenous stressors trigger a rapid rise in intracellular
calcium, followed by calpain activation, LMP, cathepsin release,
loss of plasma membrane integrity, and death within minutes to
hours41. Since the apocalyptic loss of lysosomal membrane
integrity is the focal point for somatic cell death in C. elegans, and
this mechanism is the predominant manner of death occurring in
response to multiple stressors41–45, we have now re-deﬁned this
core death pathway as lysoptosis to distinguish it from events
where LMP is a secondary event triggered by other death
routines.
Lysoptosis in C. elegans represents an example of an autonomous LDCD pathway. Lysoptosis occurs independently of other
known C. elegans cell death pathways41 and is not confounded by
the co-activation of necroptosis and pyroptosis, as the machinery
of these death routines are lacking in nematodes46,47. Based on
the molecular and morphological features of C. elegans lysoptosis,
we determined whether the signature of this ancient LDCD
pathway was conserved and/or embedded within mammalian cell
death routines. Using lysoptosis sensitizing loss-of-function
mutations in mouse and human homologs of srp-6 (mouse
2

Serpinb3a and human SERPINB3), we found that LDCD is conserved in mammals and can be activated by RCD inducers.
Interestingly, low-level LMP could be detected in most forms of
cell death, especially apoptosis. However, lysoptosis emerged as
the dominant form of cell death when the intracellular proteaseinhibitor balance was compromised.
Results
The srp-6 homologs, mouse Serpinb3a, and human SERPINB3,
protected C. elegans from lysoptosis. Nematodes null for srp-6
(srp-6(ok319)) are sensitized to lysoptosis due to the loss of cysteine
peptidase inhibitory activity in the cytosol41. We generated
transgenic lines to determine whether the expression of certain
mammalian intracellular (Clade B) serpins could prevent death48.
C. elegans expression vectors, containing a single cDNA from one
of several different intracellular serpins ligated between the srp-6
native promoter and a C-terminal GFP gene (Fig. S1a), were coinjected with a visual selection head marker (Pmyo2::mCherry) into
srp-6(ok319) animals. Serpin expression was similar to the native
srp-6 gene41 and similar to each other (Fig. S1b–d). Transgenic
lines were subjected to hypotonic stress and scored for death
(Fig. S2)41. Human SERPINB3, SERPINB4, and the mouse
orthologue, mSerpinb3a, but not SERPINB6 or SERPINB13, protected srp-6(ok319) animals from hypotonic stress (Fig. S2a)49. As
controls, we included SERPINB1 (a serine peptidase inhibitor) and
SERPINB3 with a classical inactivating P14 mutation (A341R)50.
Neither of these serpins suppressed lysoptosis in C. elegans
(Fig. S2a). This result indicated that the cysteine protease inhibitory activity of some, but not all, of the human intracellular Clade
B serpins provided a pro-survival function similar to that of C.
elegans SRP-6. These results also suggested that mSerpinb3a and
SERPINB3, and to a lesser degree SERPINB4, could serve a prosurvival function in vertebrates. However, SERPINB4, a potent
chymotrypsin serine protease inhibitor, which shares >90% amino
acid sequence identity with SERPINB3, but diverges primarily
within the C-terminal reactive site loop (RSL), demonstrated
relatively poor inhibitory kinetics against lysosomal cysteine proteases in vitro51,52.
Extensive LMP is the hallmark of lysoptosis in C. elegans. To
obtain a qualitative and quantitative assessment of LMP after
hypotonic stress, we labeled lysosomes in C. elegans with different
molecular mass ﬂuorescent dextrans (10–70 kDa)53 and exposed
the animals to hypotonic stress. srp-6(ok319) animals showed a
signiﬁcant graded and time-dependent lysosomal loss of all the
dextrans (Fig. S2u, v), whereas, N2 (wild-type) animals displayed
almost no LMP, except the low 3 kDa molecular weight dextran
was slightly but signiﬁcantly decreased (Fig. S2t, v) compared to
controls (Fig. S2r, s). These data suggested that there was
discernible LMP in wild-type animals exposed to hypotonic
stress, but lysosomal permeability was dramatically enhanced in
srp-6(ok319) animals.
Mouse Serpinb3a protected fetal intestinal epithelial cells from
lysoptosis-like death. mSerpinb3a is highly expressed in the
lung, skin, and gastrointestinal tract of mice54,55. Therefore, we
hypothesized that mSerpinb3a loss would predispose mouse
intestinal cells to stress-induced death similar to that observed
in our C. elegans model. To determine if this was the case, we
established fetal intestinal explant cultures (FIECs)56 (Fig. S3a)
from mSerpinb3a+/+ (wild-type BALB/c) and mSerpinb3a−/−
mSerpinb3a knockout (mSerpinb3a−/−) mice57. After culture
for ≥7 days mSerpinb3a+/+, FIECs expressed mSerpinb3a, as
assessed by immunoﬂuorescence and reverse-transcriptase
PCR (Fig. S3b, c).
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To determine if mSerpinb3a−/− FIECs were predisposed to
lysoptosis-like cell death, we measured their susceptibility to
hypotonic stress compared to wild-types. Neither mSerpinb3a+/+
nor mSerpinb3a−/− FIECs showed Sytox™ Green (SG) uptake in
100% DPBS (Fig. 1a, g, l and Supplementary movies 1, 2).
However, 30 min after incubation in 25% DPBS, ~10% of
mSerpinb3a+/+, and ~70% of mSerpinb3a−/− FIECs died (Fig. 1b).
This mortality was more striking at 60 min, where ~20% of the
controls, but ~90% of mSerpinb3a−/− FIECs were SG positive
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(Fig. 1b). To determine whether extensive LMP occurred prior to
cell death, as observed with C. elegans intestinal cells undergoing
lysoptosis, FIECs were labeled with tetramethylrhodamine
(TMR)-labeled 10 kDa dextran (red) and exposed to 25% DPBS
in the presence of SG. Over time, a few of the mSerpinb3a+/+
FIECs died during hypotonic stress exposure and there was a
partial loss of lysosomal content during or after the uptake of SG
(Fig. 1c–f and Supplementary Movie 3). In contrast, almost all of
mSerpinb3a−/− FIECs died with rapid disappearance of
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Fig. 1 Mouse Serpinb3a protected fetal intestinal epithelial cells (FIECs) from lysoptosis-like death. a, b mSerpinb3a+/+ (blue bars with individual data
points marked) or mSerpinb3a−/− (red bars with individual data points marked) FIECs were incubated in 100% (a) or 25% (b) DPBS for the indicated time
points. The percent dead (Sytox positive) was calculated as (# Sytox positive nuclei/# of DAPI positive nuclei) × 100. The mean ± SD were from counts
covering at least seven ﬁelds and compared using a two-tailed t-test (***P < 0.001). A representative experiment is shown. c–l Live-cell, confocal
microscopy assessed lysosomal content (red, 10 K TMR-labeled dextran), and plasma membrane permeability (green, SG) in mSerpinb3a+/+ (c–g) or
mSerpinb3a−/− (h–l). FIECs incubated in 25% (c–f, h–k) or 100% DPBS (g and l). Z series were obtained every 2 min for 1 h, indicated time points are
shown (scale bar = 25 µm); inset scale bar = 5 µm). Note marked loss of endolysosomal staining in SG positive mSerpinb3a−/− versus mSerpinb3a+/+
FIECs (k vs. f). FIECs incubated in 100% DPBS did not show SG uptake or loss of TMR-labeled dextran (g, l). Representative transmission electron
micrographs (TEM) of mSerpinb3a+/+ (m–p) or mSerpinb3a−/− (q–t) FIECs after incubation in 25% DPBS (m, n, o and q, r, s) or 100% DPBS (p and t). Low
magniﬁcation (scale bar =2 µm) TEM images of mSerpinb3a+/+ or mSerpinb3a−/− FIECs (m, p and q, t, respectively) show cell morphology. High
magniﬁcation (scale bar =100 nm) TEM images (n, o and r, s, respectively) demonstrate cell morphology. n and r were magniﬁed cells from within the
hashed box in m and q, respectively. o and s were individual cells from a different ﬁeld of view. Some mSerpinb3a+/+ FIECs exhibit hallmarks of apoptotic
morphology (n), including chromatin condensation (black arrowheads) and plasma membrane budding (open arrowheads), or necrotic morphology (o),
including plasma membrane breaks (black arrows) and organelle degeneration (open arrows). mSerpinb3a−/− FIECs displayed a necrotic cell death
morphology (black and open arrows as above) along with severe vacuolization and cytoplasmic clearing (asterisks) (r, s). Original imaging data ﬁles can be
found at https://data.mendeley.com/datasets/hk2t9x7d6x/1.

endolysosomal staining prior to SG uptake (Fig. 1h–k and
Supplementary Movie 4).
Transmission electron microscopy (TEM) ultrastructural
changes of FIECs incubated in 25% DPBS for 1 h indicated more
cell death in mSerpinb3a−/− FIECs. An occasional dead cell from
mSerpinb3a+/+ FIECs showed apoptosis with membrane budding
and chromatin condensation (Fig. 1m, n), or necrosis with
cytoplasmic vacuolization and loss of plasma membrane integrity
(Fig. 1o)15. In contrast, mSerpinb3a−/− FIECs exclusively showed
a necrotic-like phenotype consisting of nucleocytoplasmic and
organellar swelling, vacuolization, and loss of lysosomal and
plasma membrane integrity (Fig. 1q–s)15. FIECs from both
strains treated with 100% DPBS appeared normal (Fig. 1p, t). We
concluded that mSerpinb3a−/− FIECs were sensitized to
lysoptosis-like cell death similar to that observed in srp6(ok319) C. elegans intestinal cells exposed to hypotonic stress41.
Lysoptosis-like death in mSerpinb3a−/− FIECs required LMP
and lysosomal cysteine peptidases, but not executioner caspases. In srp-6(ok319) C. elegans, lysoptosis occurred in the absence
of caspases, but required LMP and the cytoplasmic release of lysosomal cysteine peptidases41. To determine if mSerpinb3a−/− FIECs
exposed to hypotonic stress were undergoing apoptosis or lysoptosis,
we utilized ﬂuorescent markers of lysosomal injury and different
protease inhibitors. FIECs were incubated with the endolysosomal
marker, Alexaﬂuor647 conjugated to 10 kDa dextran (dextran647),
and with either the pan-cysteine protease inhibitor, E64d, or the
executioner caspase-3/7 inhibitor, DEVD-CHO. To determine
whether hypotonic stress might also activate apoptosis, cultures were
assayed for evidence of apoptosis with the phosphatidylserine
marker, FITC-labeled Annexin V (green), and the necrosis marker,
propidium iodide (PI, red). Minimal cell death (<10%) was detected
in the mSerpinb3a+/+ FIECs incubated in 25% DPBS (Fig. 2a–l, y).
Neither DMSO (diluent), E64d, nor DEVD-CHO had an effect on
cell viability (Fig. 2c, y). Lysosomal staining also remained intact
(Fig. 2d, h, l, z). In contrast, mSerpinb3a−/− FIECs showed increased
PI uptake, but not annexin V staining, upon exposure to 25% DPBS
(Fig. 2m-x,y). Cell death was associated with the complete loss of
endolysosomal staining (dextran647, Fig. 2p, z) and was mostly
blocked by pre-incubation with E64d, but not DEVD-CHO (Fig. 2t,
x, z). These data suggested that the cysteine proteases triggered an
increase in both lysosomal and plasma membrane permeability in
mSerpinb3a−/− FIECs exposed to hypotonic stress. Moreover, neither caspase activation nor plasma membrane externalization of
phosphatidylserine (markers of apoptosis) were associated with this
lysoptosis-like phenotype.
4

Necrostatin-1 fails to inhibit lysoptosis-like death in mSerpinb3a−/− FIECs. To determine whether mSerpinb3a+/+ or
mSerpinb3a−/− FIECs exposed to hypotonic stress were undergoing
necroptosis, cells were treated with nec-1 prior to incubation in 25%
DPBS (Fig. 2i–xiv). We found ~20% of mSerpinb3a+/+ FIECs died,
as deﬁned by PI uptake (Fig. 2i–vi, xiii). Nec-1 provided partial
protection in this experiment, although overall death was minimal
(Fig. 2xii). However, there was no decrease in the lysosomal content
between the nec-1 treated or untreated mSerpinb3a+/+ FIECs
(Fig. 2iii, vi, xiv). This lack of effect may be attributed to the relatively late-appearing LMP associated with necroptosis13. In contrast,
~60% mSerpinb3a−/− FIECs died (Fig. 2vii–xiii). Nec-1 neither
protected these cells from death, nor blocked the marked LMP
associated with PI uptake (Fig. 2vii, ix, xi–xiv).
Apoptosis and necroptosis inducers preferentially triggered
lysoptosis-like cell death in mSerpinb3a−/− FIECs. Since DEVDCHO failed to block lysoptosis-like cell death in mSerpinb3a−/−
FIECs, we assessed whether this inhibitor was ineffective in FIECs,
or the executioner phase of apoptosis was nonoperational under
these conditions. We induced apoptosis and necroptosis in mSerpinb3a+/+ and mSerpinb3a−/− FIECs by treating the cultures with
the protein kinase C inhibitor, STS and STS combined with the pancaspase inhibitor, z-VAD-fmk, respectively58,59. After treatment
with STS, mSerpinb3a+/+ FIECs showed increased annexin V
staining without PI uptake (Fig. 3a–c, g–i, m–o, s, t). These results
are consistent with the induction of apoptosis in mSerpinb3a+/+
FIECs. Surprisingly, the mSerpinb3a−/− FIECs showed little annexin
V staining in response to STS, but a signiﬁcant increase in PI uptake
(Fig. 3d–f, j–l, s, t). Moreover, the PI uptake in mSerpinb3a−/−
FIECs was comparable to that observed in FIECs incubated in 25%
DPBS for 2 h (Fig. 3p–r, t). To ensure that annexin V staining had
not escaped detection due to accelerated necrosis, we performed livecell time-lapsed imaging of mSerpinb3a−/− FIECs during incubation
with STS (Fig. S4). Minimal annexin V staining was detected,
although PI-positive cells were detected as early as 2 h after treatment. In contrast, mSerpinb3a+/+ FIECs were annexin V positive as
early as 2 h with a few PI-positive cells detected by 8 h (Fig. S4).
mSerpinb3a+/+ FIECs exposed to STS and z-VAD-fmk showed
increased necrotic-like cell death as shown by PI uptake, and
death was inhibited markedly by the RIPK1 inhibitor, nec-160
(Fig. 3u, w, y). mSerpinb3a−/− FIECs treated with STS and
z-VAD-fmk also showed signiﬁcant necrotic-like cell death as
evident by PI uptake (Fig. 3v, x, y). Unlike mSerpinb3a+/+ FIECs,
mSerpinb3a−/− FIECs were not protected from cell death by
nec-1 (Fig. 3w, x, y). We concluded that mSerpinb3a+/+ FIECs
were capable of undergoing apoptosis and necroptosis, but that

COMMUNICATIONS BIOLOGY | (2022)5:47 | https://doi.org/10.1038/s42003-021-02953-x | www.nature.com/commsbio

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02953-x

mSerpinb3a−/− FIECs preferentially demonstrated a lysoptosislike death phenotype in response to the same cell death inducers.
Moreover, mSerpinb3a−/− FIECs were more sensitive to classic
apoptosis- and necrosis-inducing agents as evidenced by higher
cell death under equivalent conditions.
To determine whether apoptosis or necroptosis contributed to cell
death in mSerpinb3a−/− FIECs, or if a lysoptosis-like pathway was
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executed before either RCD routine became fully activated, required
additional investigation. Unfortunately, biochemical studies in FIECs
are impractical due to their small colony sizes and fastidious culture
conditions. To overcome this limitation, we re-assessed these RCD
routines in human immortalized tumor cell lines that expressed high
levels of SERPINB3 (human mSerpinb3a orthologue). Two different
human cervical carcinoma cell lines, “wild-type” (SW756B3-WT and
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Fig. 2 LMP and lysosomal cysteine peptidases, but not executioner caspases or RIPK1, induced lysoptosis-like death in mSerpinb3a−/− FIECs.
a-x Representative confocal ﬂuorescence images of mSerpinb3a+/+ (a-l) or mSerpinb3a−/− (m-x) FIECs pretreated with diluent (DMSO; a-d; m-p), 2 µM
DEVD-CHO (e-h; q-t) or 2 µM E64d (i-l; u-x) and then incubated in 25% DPBS for 1 h (scale bar = 40 µm). FIECs were stained with Hoescht 33342
(H33342; blue), annexin V-FITC (annexin V, green), propidium iodide (PI, red), and Alexaﬂuor647 conjugated dextran (dextran647, white). y, z
Quantiﬁcation of dead cells (PI-positive; y) or lysosomal area (dextran647 staining; z) from different representative experiments (n = 3) over multiple ﬁelds
(n > 5). i-xii Confocal maximum intensity projections of ﬂuorescently labeled lysosomes from mSerpinb3a+/+ (i–vi) or mSerpinb3a−/− (vii–xii) FIECs (scale
bar = 25 µm). Cultures were pretreated with DMSO (i-iii; vii-ix) or nec-1 (iv-vi; x-xii) for 1 h prior to incubation in 25% DPBS. Cell numbers, cell death, and
lysosomes were quantitated using H33342 (blue), PI (red), and dextran647 (white), respectively. Representative images are from the same experiment,
which was repeated three times. xii, xiv Quantiﬁcation of PI positive (xii) or lysosomal (xiv) staining from multiple ﬁelds (n ≥ 6). The means ± SD of a
representative experiment were compared using a two-way ANOVA with Tukey’s multiple comparisons (**P < 0.01, ***P < 0.001). Original data ﬁles can
be found at https://data.mendeley.com/datasets/scgbb3s333/1.

HT3B3-WT) or null (SW756B3-KO and HT3B3-KO) for SERPINB3,
were generated using CRISPR/Cas9 technology (Fig. S5)61.

SERPINB3 null human tumor cell lines exposed to hypotonic
stress undergo lysoptosis-like cell death. HT3B3-WT and HT3B3-KO
cell lines were incubated in 10% DPBS and examined for cell death
by PI uptake. HT3B3-KO cells showed >50% mortality compared to
the HT3B3-WT controls (Fig. 4a, b). Although the HT3B3-WT cell
death was relatively small and variable (<20%), it was still detectable
(compare Figs. 4a, b). This suggested that both cell lines were susceptible to hypotonic stress, but as in C. elegans and mouse FIECs,
serpin loss exacerbated the cell death phenotype. Similar results were
obtained with the SW756B3-WT and SW756B3-KO cell lines (Fig. S6).
Moreover, the expression of SERPINB3, but not SERPINB3A341R 50,
nor, in this case, SERPINB4 rescued the HT3B3-KO cells from
hypotonic stress (Fig. S7). Other mechanistically different cysteine
protease inhibitors of various efﬁcacy; including cystatin A, cystatin
B62, SERPINB163, SERPINB664, and SERPINB1365, were detected by
quantitative RT-PCR in both tumor cell lines (Fig. S8a). However,
only SERPINB1 was detectable in all the cells lines by immunoblotting (Fig. S8b). Considering the inability of SERPINB1 to rescue
srp-6 null C. elegans (Fig. S2), these rescue data suggested that the loss
of SERPINB3 alone was responsible for enhanced sensitivity to
hypotonic stress. Cell death was blocked in the HT3B3-KO cells by
pre-incubation with E64d, but not DEVD-CHO (Fig. 4a, b), and
characterized by a nearly complete loss of endolysosomal staining
(Fig. 4c–n). Similar to srp-6(ok319) animals, LMP assessed by the loss
of ﬂuorescently labeled lysosomal dextrans, ranging from 3–70 kDa,
showed a signiﬁcant acceleration in HT3B3-KO cells compared to
HT3B3-WT cells (Figs. 4o–s, S9). LMP can be induced by ROS66, and
a mouse serpin, Spi2A, protects mouse embryonic ﬁbroblasts from
cell death by inhibition of cathepsin B (CTSB)67. However, after
treatment of either HT3B3-WT and HT3B3-KO cells with hypotonic
stress, no signiﬁcant increase in intracellular ROS was detected by the
cell-permeant ﬂuorescent ROS indicator, 2’,7’-dichlorodihydroﬂuorescein diacetate (H2-DCFDA; Fig. S10a). As a control, treatment
with the ROS producer, tBOOH, increased H2-DCFDA ﬂuorescence
intensity in both cell lines (Fig. S10a). tBOOH-induced ﬂuorescence
exceeded that observed after hypotonic DPBS exposure, although no
death was detected after 2% tBOOH treatment. Thus, the marginal
(statistically non-signiﬁcant) increase in ROS detected after hypotonic
DPBS exposure did not, in itself, appear to be toxic to either the
HT3B3-WT or HT3B3-KO cells (Fig. S10b). Upon exposure to 15%
DPBS, and compared to HT3B3-WT cells, HT3B3-KO cells examined
by TEM showed cytoplasmic and nuclear swelling, loss of organellar
architecture, and degeneration of the plasma membrane (Figs. 4t–x
and S11). HT3B3-WT cells showed similar morphology, but the
damage was neither as severe nor as frequent compared to the
HT3B3-KO cells (Figs. 4t–x and S11). We concluded that this cell
death phenotype resembled the lysoptosis-like cell death observed in
mSerpinb3a−/− FIECs exposed to hypotonic stress.
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The lysoptosis-like cell death pathway involves promiscuous
cytoplasmic proteolytic activity in human cell lines. During
lysoptosis in C. elegans, we detected cytosolic cysteine protease
activity using the quenched ﬂuorogenic substrate zFR-R110, which
ﬂuoresces green upon cleavage by proteolytic enzymes41. To determine whether lysosomal proteases released into the cytosol were
involved in the lysoptosis-like cell death pathway, we ﬁrst determined which lysosomal proteases (including the most common
cysteine proteases, CTSL and CTSB; and the cysteine protease
processing aspartic protease, CTSD) were detectable in parental HT3
and SW756 cell lines using quantitative RT-PCR and immunoblotting (Fig. S12). We detected CTSB, -D, and -L transcripts and
protein in both cell types regardless of SERPINB3 status
(Fig. S12a–e, h, i). CTSS, -K, or -V transcripts were undetectable by
quantitative RT-PCR (Fig. S12a). Neither CTSS nor -K was detected
by immunoblotting (Fig. S12–n-u). A scant amount of CTSV protein was present in the SW756 cell line (Fig. S12j, k). These data
suggested that CTSL and -B were the major cysteine CTSs expressed
in the HT3 and SW756 cell lines. To monitor the release of cysteine
CTS activity into the cytosol, we utilized a differential cell lysis
procedure that facilitates the diffusion of cytosolic contents into the
media without affecting lysosomal membrane integrity68,69. In HT3
cells, low concentration digitonin (<25 µg/ml) permeabilized the
high cholesterol-containing plasma membrane, whereas higher
concentrations (>25 µg/ml) also perforated subcellular vesicle
membranes, including the lysosomes (Fig. S13a, b). As expected,
cytosolic GAPDH was detected in all culture supernatants obtained
from both HT3B3-WT and HT3B3-KO cells, regardless if they were
treated with either 10 or 100% DPBS and exposed to either low
(20 µg/ml) or high (200 µg/ml) digitonin concentrations. Similarly,
the cytosolic protein, SERPINB3, was also detected in these same
supernatants, except not those from HT3B3-KO cells. As a marker for
LMP, we analyzed CTSL content by immunoblotting. Unsurprisingly, CTSL was detected in supernatants obtained after 200 µg/ml
digitonin treatment in both HT3B3-WT and HT3B3-KO cells incubated in 100% DPBS (Fig. 5a). In contrast, incubation in 10% DPBS,
but not 100% DPBS, and the low digitonin concentration, revealed
the presence of CTSL in the supernatant from both HT3B3-WT and
HT3B3-KO cells (Fig. 5a). To assess for actual leaked cytosolic protease activity, we assayed for cleavage of the quenched ﬂuorogenic
cysteine protease substrate, zFR-R110. There was relatively more
activity detected in supernatants from HT3B3-KO than HT3B3-WT
cells treated with 10% DPBS and the low concentration of digitonin
(Fig. 5b). Taken together, we concluded that cellular stress-induced
LMP and the release of active lysosomal cysteine proteases into the
cytosol of both HT3B3-WT and HT3B3-KO cell lines. However, it was
the absence of SERPINB3 neutralizing activity that led to unchecked
lysosomal derived cytosolic proteolysis, followed by subcellular
injury and, eventually, the lysoptosis-like cell death phenotype.
In C. elegans, the lysosomal proteases, ASP-1, CPR-6, and CPL-1
(human CTSD, CTSB, and CTSL homologs, respectively) are
necessary for lysoptosis41 and all three human homologs were
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present in the SW756 cell lines (Fig. S12). However, CTSD is an
aspartic protease family member and both human SERPINB3 and
mouse Serpinb3a failed to inhibit CTSB in vitro52,70. Thus, we
reasoned that the CTSL protease would be the most likely target for
SERPINB3 and be required for lysoptosis-like cell death in human
cells. We generated CTSL knockout cell cultures in both SW756B3-WT
and SW756B3-KO cells using CRISPR/cas9 technology (Table S1). As

ARTICLE

expected, the SW756B3-KO;CTSL-WT cell lines were more sensitive to
10% DPBS treatment than SW756B3-WT;CTSL-WT (Fig. 5c). However,
the SW756B3-KO;CTSL-KO cell line signiﬁcantly protected the
SW756B3-KO cells from death (Fig. 5c). Moreover, pretreatment of
the HT3B3-KO cell line with the selective cathepsin L inhibitor,
CAA022571, for 1 h at 10 µM prior to treatment with hypotonic stress
protected the cells from death, similar to the E64d control at the same
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Fig. 3 Apoptosis or necroptosis inducers preferentially triggered lysoptosis-like cell death in mSerpinb3a−/− FIECs. a–r To assess apoptosis,
mSerpinb3a+/+ or mSerpinb3a−/− FIECs were treated with 100% PBS (a–f), 1 µM staurosporine (STS) for 16 h (g–l), or 25% PBS for 2 h (m–r).
Representative confocal ﬂuorescence maximum intensity projections were of cells stained with Hoechst 33342 (blue), annexin V-FITC (green), and PI (red;
scale bars = 25 µm). s–t Quantiﬁcation of annexin V (s) and PI (t) staining in multiple ﬁelds (n ≥ 5) from a representative of three experiments using
mSerpinb3a+/+ (blue) or mSerpinb3a−/− (red) FIECs treated with 100% PBS (control), 1 µM STS for 16 h or 25% PBS for 2 h. u–x To induce necroptosis,
mSerpinb3a+/+ (u, w), or mSerpinb3a−/− (v, x) FIECs were pretreated with either DMSO or 5 µM nec-1 and then incubated with 1 µM STS with 10 µM zVAD-fmk for 16 h. Representative merged confocal ﬂuorescence maximum intensity projections were of cells stained with H33342 (blue) and PI (red, scale
bar = 25 µm). Dually labeled nuclei indicated dead cells and were depicted as magenta. y Quantiﬁcation of PI staining in multiple ﬁelds from a
representative of three experiments of mSerpinb3a+/+ or mSerpinb3a−/− FIECS pretreated with DMSO or 5 µM nec-1 and induced for necroptosis by
treatment with 10 µM STS with 1 µM z-VAD-fmk for 16 h. For data in s, t, and y, the means ± SD were compared using a two-tailed t-test (***P < 0.001,
**P < 0.01). Original data ﬁles can be found https://data.mendeley.com/datasets/4gfrf8xkyf/1.

concentration (Fig. 5d). Similar to C. elegans41, these data suggested
that CTSL, a major target of SERPINB3 in vitro, was an essential
component of the mammalian lysoptosis-like cell death pathway.

Induction of apoptosis in SERPINB3 null tumor cells activated
executioner caspases, but a lysoptosis-like cell death phenotype.
Since mSerpinb3a−/− FIECs treated with STS demonstrated a cell
death phenotype more consistent with lysoptosis, rather than apoptosis, we treated both HT3B3-KO and HT3B3-WT cells with STS and
assayed for cell death. Both cell lines showed a comparable increase in
caspase-3/7 activation, as measured by an increase in ﬂuorescence of
a quenched executioner caspase substrate (NucView) (Fig. 6a). This
activity was blocked by the caspase inhibitor, DEVD-CHO, but not
the pan-cysteine peptidase inhibitor, E64d (Fig. 6a). Consistent with
induction of apoptosis by STS, caspase-3 and PARP cleavage were
detected in both cell lines (Fig. 6b). HT3B3-WT cells also showed
annexin V staining (Fig. 6c–e, i–k, o) without an increase in PI or SG
uptake (Fig. 6c–e, i–k, p). In contrast, HT3B3-KO cells showed
minimal annexin V staining, but a marked increase in PI or SG
uptake (Fig. 6f–h, l–n, p, q). This observation indicated an early loss
of plasma membrane integrity, which is atypical for the early stages of
apoptosis. Of note, SG uptake in HT3B3-KO cells was decreased after
pre-incubation with E64d, but not DEVD-CHO (Fig. 6q).
We next examined lysosomal membrane integrity in STS
treated cells. HT3B3-WT cells showed a modest but signiﬁcant
decrease in LysotrackerTM staining, but no increase in SG uptake
(Fig. S14). In contrast, HT3B3-KO cells showed nearly a complete
loss of LysotrackerTM staining concomitant with increased SG
uptake (Fig. S14). We next assessed LMP by the loss of
ﬂuorescently labeled lysosomal dextrans. Interestingly, both cell
lines showed a rapid and comparable loss of the 3 kDa dextran
(Fig. 6r–v). However, only the HT3B3-KO cells showed a
signiﬁcant loss of the higher molecular mass forms, reminiscent
of HT3B3-KO cells exposed to hypotonic stress (Fig. 6r–v
compared to Fig. 4o–s). TEMs of STS treated cells, showed
typical morphological features of apoptosis in HT3B3-WT cells,
with membrane budding, and chromatin condensation and
fragmentation (Fig. 6w, y). In contrast, HT3B3-KO cells showed
an obvious necrotic-like phenotype with swollen nuclei, cytoplasmic vacuolization, and loss of plasma membrane integrity
(Fig. 6x, z). Taken together, these studies suggested that STS induced
canonical caspase-3/7-dependent apoptotic death in HT3B3-WT cells
with minimal LMP. In HT3B3-KO cells exposed to STS, caspase-3/7
was activated. However, the lack of protection by DEVD-CHO and
necrotic morphology suggested that the intrinsic apoptosis signaling
by STS led to a subtle perturbation of lysosomal membrane integrity
(loss of 3 kDa dextran), which rapidly deteriorated in the absence of
SERPINB3. The net result was the emergence of a lysoptosis-like cell
death phenotype in HT3B3-KO cells.

8

Lysoptosis-like cell death is a distinct form of regulated
necrosis. Mitochondrial permeability transition-driven necrosis
(MPT-DN), necroptosis, ferroptosis, and pyroptosis are four
distinct, well-characterized regulated necrosis pathways that are
differentiated by their mechanisms of induction, signaling cascades, pharmacologic or molecular inhibitors, and death
effectors1,2. Since lysosomal membrane instability has been
associated with all death routines11, we determined whether the
loss of SERPINB3 predisposed cells to lysoptosis-like cell death or
sensitized them to one or more regulated necrosis pathways.

MPT-DN. The necrotic-like cell death pathway, MPT-DN, results
from the opening of the calcium-gated mitochondrial permeability
transition pore complex (PTPC) which is inhibited by Cyclosporin
A (CsA)72. The role of LMP in MPT-DN is ill-deﬁned, however,
the neutralization of lysosomal activity by chloroquine can block
MPT-DN73. To determine the role of LMP in MPT-DN, we
treated HT3B3-KO and HT3B3-WT cells with the MPT-DN inducer,
hydrogen peroxide (H2O2). To ensure that H2O2 induced MPT,
we used the ﬂuorescence probe, JC-1 which ﬂuoresces red in
healthy mitochondria but, upon depolarization of the mitochondrial membrane, allows the escape of green ﬂuorescent JC-1
monomers into the cytoplasm74. After treatment with H2O2, both
cell lines showed comparable increases in MPT indicated by
increased JC-1 green ﬂuorescence (Fig. 7a–n). However, the
degree of cell death, as indicated by SG uptake, was signiﬁcantly
increased in HT3B3-KO cells compared to HT3B3-WT cells
(Fig. 7o). CsA protected HT3B3-WT cells from H2O2 toxicity, but
had no effect on HT3B3-KO cells death (Fig. 7p). In contrast, E64d
failed to protect signiﬁcantly HT3B3-WT, whereas cell death was
signiﬁcantly decreased in HT3B3-KO cells (Fig. 7p). Since lysosomal integrity by Lysotracker staining was more compromised in
HT3B3-KO cells as compared to HT3B3-WT cells treated with H2O2
(Fig. S15), we assessed LMP using ﬂuorescently labeled dextrans.
HT3B3-WT cells showed appreciable release of only 3 kDa dextran,
whereas HT3B3-KO cells demonstrated a signiﬁcant decay of the
3–70 kDa dextrans (Fig. 7q–u). These data suggested that LMP
was not a dominant feature in the HT3B3-WT cells undergoing
MPT-DN. TEMs showed evidence of necrosis with pan-cellular
swelling and vacuolization in both cell lines, but was more pronounced in HT3B3-KO cells (Fig. 7v–z). Comparable mitochondrial degeneration was observed in both cells (Fig. 7v–y, aa). We
concluded that H2O2 triggered upstream events in the MPT-DN
pathway (i.e., mitochondrial injury) in both the HT3B3-WT and
HT3B3-KO cell lines. However, in the HT3B3-KO cells, the loss of
SERPINB3 enhanced the effects of LMP resulting in a lysoptosis
phenotype that killed the cells. Lysoptosis likely interrupted the
MPT-DN pathway before it was fully activated and explains why
E64, but not CsA, was partially protective in HT3B3-KO cells.
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Ferroptosis. Reactive oxygen species (ROS) generated by the irondependent Fenton reaction, depletion of glutathione, and lipid
peroxidation result in ferroptosis. Morphologically ferroptosis is
distinguished by mitochondrial condensation, increased membrane
density and lost cristae75. Ferroptosis is triggered by either erastin or

ARTICLE

RSL376,77 and is inhibited by ferrostatin-1 (fer-1)78. Although evidence of LMP has been described10,79, lysosomal iron stores and
proteases appear to be dispensable for ferroptosis75. To determine
the role, if any, of SERPINB3 in ferroptosis, SW576B3-WT and
SW576B3-KO cells were treated with erastin77 and the ﬂuorescent
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Fig. 4 Hypotonic stress induces lysoptosis-like death in human tumor cell lines null for SERPINB3. a, b HT3B3-WT (blue) or HT3B3-KO (red) cells were
incubated with DMSO, 2 µM E64d (a, b), or 10 µM DEVD-CHO (DEVD; b) for 1 h prior to exposure to 100% or 10% DPBS for 4 h, and stained with SG and
H33342. Percent dead was calculated as (# Sytox positive nuclei/# of blue nuclei) × 100. c–n Representative confocal images (scale bar = 25 µm) of
HT3B3-WT or HT3B3-KO cell lines treated with 100% DPBS or 10% DPBS for 4 h and then stained with H33342 (blue; c, f, i, l), Lysotracker™ deep red
(white; d, g, j, m), and PI (red; e, h, k, n). o–r To quantify LMP, HT3B3-WT (o, q), or HT3B3-KO (p, r) cells were incubated with 3 kDa Cascade blue, 10 kDa
Alexa488, 40 kDa TMR, and 70 kDa Texas red conjugated dextrans prior to exposure to 100 or 10% DPBS and imaged using live-cell resonance scanning
confocal microscopy (≥10 ﬁelds, ≥20 z-planes). The number of lysosomes at each time point (LCt) were normalized to the initial lysosome count at time
zero (LCt0). s Area under the curve (AUC) for each dextran over time for both HT3B3-WT (left) or HT3B3-KO (right) cells treated with 100 or 10% PBS.
Statistical signiﬁcance was determined using a two-way ANOVA with Tukey’s multiple comparisons test. t–w Representative TEM images (scale
bars = 500 nm) of HT3B3-WT or HT3B3-KO cells treated with 100 or 15% DPBS for 4 h. Vacuolization (closed arrowheads) was noted in the HT3B3-KO, and
to a lesser extent in the HT3B3-WT cells, treated with 15% DPBS. x Blinded scoring of the percentage of necrotic appearing cells in 2000x magniﬁcation
TEM images (≥20 ﬁelds) of HT3B3-WT or HT3B3-KO cells treated with 100 or 15% DPBS for 4 h. Unless otherwise noted, a representative of ≥3 replicates is
shown, and the means ± SD were compared using a two-way ANOVA with Tukeys’ multiple comparisons (ns not signiﬁcant, ***P < 0.001, **P < 0.01).
Original data ﬁles can be found at https://data.mendeley.com/datasets/gnwb39t76k/1.

ROS indicator, H2-DCFDA. Both cell lines showed a comparable
increase in ﬂuorescence that peaked ~10–12 h after erastin treatment
(Fig. 8a–e). As indicated by SytoxTM Orange uptake, the degree of
erastin-induced death in the SW756B3-KO and SW756B3-WT cell
lines was similar (Fig. 8f). Death was blocked completely by fer-1,
but not by E64d (Fig. 8g). While both cell lines similarly showed a
slight decrease in LysoTracker® Red staining with erastin treatment
(Fig. 8h–l), minimal LMP was detected, with partial loss of both the
3 and 10 kDa dextran markers in only the SW756B3-KO cells
(Fig. 8m–q). Both cell lines showed morphological features of ferroptosis, with shrunken mitochondria, dense membranes and loss of
cristae (Fig. 8r–w)75. We concluded that the ferroptosis RCD
pathway neither triggered signiﬁcant LMP nor activated the
lysoptosis-like pathway even in the absence of SERPINB3.
Necroptosis. Necroptosis is executed via its core machinery;
receptor-interacting serine/threonine-protein kinase 1 (RIPK1),
RIPK3, and mixed-lineage kinase domain-like pseudokinase
(MLKL)80. While necroptosis is thought to be an executioner
protease-independent pathway81, in macrophages, lysosomal
cysteine peptidases can cleave RIPK1 and impair necroptosis
signaling82. Given our ﬁndings in FIECs, we determined whether
LMP and SERPINB3 loss altered necroptosis, induced by TNFα, a
SMAC mimetic (BV6), a pan-caspase inhibitor (qVD-Oph), and
cycloheximide (T + S + Q + C). HT3B3-KO cells demonstrated
more cell death than HT3B3-WT cells (Fig. 9a, r). Nec-1 completely
blocked cell death in the HT3B3-WT cells, but only partially in
HT3B3-KO cells (Fig. 9b). In contrast, treatment of E64d had no
effect on the death of HT3B3-WT cells, whereas it inhibited death in
HT3B3-KO cells to a greater extent than that of nec-1 (Fig. 9b).
Immunoblotting with anti-phospho-RIPK1 demonstrated that
necroptosis was activated by T + S + Q + C in both cell lines
(Fig. 9c). Similarly, immunoﬂuorescence staining with antiphospho-MLKL showed that MLKL was phosphorylated in
HT3B3-WT and HT29 positive control cells after necroptosis
induction, but very little staining was observed in HT3B3-KO cells
(Fig. S16). Staining with LysoTracker® Deep Red, indicated that the
endolysosomal compartment was compromised more extensively in
HT3B3-KO cells than HT3B3-WT cells (Fig. 9d–h). In addition, LMP
was increased in HT3B3-KO compared to HT3B3-WT cells, demonstrated by the signiﬁcant lysosomal leakage of the 3–70 kDa dextrans (Fig. 9i–m). By TEM, HT3B3-WT cells were intact with some
heterochromatin clumping (Fig. 9n, o). In contrast, more HT3B3-KO
cells were swollen with cytoplasmic vacuolization and clearing, and
occasional vacuolar and plasma membrane breaks (Fig. 9p, q, r).
This morphology was consistent with a lysoptosis-like phenotype.
We concluded that HT3 cells underwent RIPK1 and MLKLdependent cell death routine consistent with necroptosis in
response to T + S + Q + C, but LMP did not contribute
10

appreciably to their demise. In the absence of SERPINB3, however,
LMP was more extensive with cells converting to a lysoptosis-like
death before a necroptosis phenotype emerged.
Pyroptosis. The activation of cytosolic pattern recognition receptors, such as inﬂammasomes, leads to CASP1 activation, processing
of inﬂammatory cytokines (pro-IL-1β and pro-IL-18), and cleavage
of gasdermin D (GSDMD)83. N-terminal GSDMD cleavage fragments polymerize and form pores within the plasma membrane
leading to mature IL-1β and IL-18 release and associated lytic cell
death83. The role of LMP in pyroptosis is confounded by studies
showing that cytosolic cysteine peptidase activity can both activate
and inhibit pyroptosis signaling84–86. We hypothesized that if
increased LMP contributed to pyroptosis-induced lytic death, then
the absence of SERPINB3 should augment cell death in response to
a nucleotide-binding domain and leucine-rich repeat-containing
(NLR) protein 3 (NLRP3) inﬂammasome activation. HT3B3-WT
and HT3B3-KO cell lines were treated with several different NLRP3
inﬂammasome activators after LPS priming87. Nigericin-induced
cell death (Fig. S17a). SytoxTM Orange uptake was signiﬁcantly
increased in the HT3B3-KO compared to HT3B3-WT cells. Live-cell
confocal imaging indicated that there was a loss of 10 kDa TMRlabeled dextran staining in both HT3B3-WT and HT3B3-KO cell lines,
with more Sytox positive cells in HT3B3-KO (Fig. S17a, b). Moreover, LMP was observed equally in both HT3 cell lines as
demonstrated by equivalent loss of 3–70 kDa labeled dextrans
(Fig. S17c–g). Unlike the pyroptosis-prone THP cells, neither
GSDMD nor caspase-1 cleavage was detected in either HT3 cell line
exposed to varying concentrations of nigericin (Fig. S17h, i)88.
Interestingly, both HT3 cell lines were protected by incubation with
E64d, but minimally by z-VAD or YVAD (Fig. S17i, j, k). As
expected, THP1 cells were protected by these caspase inhibitors and
E64d (Fig. S17l). These data suggested that nigericin-induced LMP
and cell death, reminiscent of lysoptosis, but not pyroptosis, in both
HT3 cell lines, with HT3B3-KO cells being more susceptible.
The cell lines were also incubated with an alternative NLRP3
inducer, Staphylococcus aureus α-hemolysin (Hla)89,90. HT3B3-WT
cells showed increased SG uptake compared to HT3B3-KO cells
(Fig. S18a). However, while the THP1 control cell line showed
GSDMD cleavage, immunoblots from cell lysates from both HT3
cell lines detected cleavage of GSDME, but not GSDMD (Fig. S18b),
supporting an alternative signaling pathway in HT3 cells. GSDME
is cleaved to yield a functional N-terminal domain by CASP3, not
CASP191. This interpretation was consistent with protease
inhibitor data, where z-VAD-fmk (pan-caspase inhibitor), but
not VX735 (CASP1 inhibitor) or E64d, protected the cells from
Hla-induced death (Fig. S18c–e). The lack of protection by E64d
suggested that LMP was not involved in GSDME-associated cell
death, which was underscored by the minimal loss of
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Fig. 5 The lysoptosis-like cell death pathway involves promiscuous cytoplasmic proteolytic activity. a Western blot analysis of lysosomal CTSL (goat
polyclonal cathepsin L, Novus, AF952), nucleocytoplasmic SERPINB3 (α-B3; rabbit polyclonal SERPINB3/B4), and cytosolic GAPDH () in supernatants of
HT3B3-WT and HT3B3-KO cell lines treated with 100 or 10% DPBS for 30 min at 37 °C, 5% CO2 prior to treatment with DPBS containing 0, 20, or 200 µg/ml
digitonin. The relative band intensities (rel. int.) for each lane were calculated (Image Lab, v6.1, Bio-Rad) and are shown under the corresponding lane. Note
the detection of CTSL in the 20 µg/ml digitonin supernatants of both HT3B3-WT and HT3B3-KO treated with 10% DPBS but not the 100% DPBS controls. Black
arrowheads indicate full-length proteins, gray and open arrowheads demark processed active forms of CTSL. b Pan-lysosomal cysteine protease activity (zFRR110). Activity in supernatants of HT3B3-WT and HT3B3-KO cell lines treated with 100 or 10% DPBS for 30 min at 37 °C, 5% CO2 prior to treatment with DPBS
containing 0, 20, or 200 µg/ml digitonin. The activity was normalized to the 200 µg/ml control to account for total lysosomal cysteine protease protein
levels. Note, the signiﬁcantly enhanced cysteine protease activity in HT3B3-KO cytosolic supernatants (20 µg/ml digitonin) compared to HT3B3-WT in 10%
DPBS cells treatment. c Bulk CTSL-KO SW756B3-WT or SW756B3-KO cell lines were generated by CRISPR/cas9 methodology. The percentage of the bulk
population containing indels in the CTSL gene was conﬁrmed by NGS sequencing (Table S1) and CTSL protein levels are shown in ref. 114. Cell lines were then
treated with either 100 or 10% DPBS in the presence of SG for 4 h. The % dead was calculated as the number of SG positive cells/the total number of cells as
determined by high contrast brightﬁeld imaging × 100. Analyses were compared using a two-way ANOVA with Tukeys’ multiple comparisons (n ≥ 10
replicates; *** P < 0.001). Note, the statistically signiﬁcant reduction in % dead between SW756B3-KO;CTSL-WT and SW756B3-KO;CTSL-KO. d HT3B3-WT or
HT3B3-KO cells were incubated with DMSO, 10 µM E64d, or 10 µM cathepsin L selective inhibitor, CAA0225 for 1 h prior to exposure to 100 or 10% DPBS for
14 h, and stained with SG. Percent dead was calculated as ((Sytox positive nuclei/total cells calculated by brightﬁeld microscopy) × 100) (n = 5 replicates; ns
not signiﬁcant, *** P < 0.001). Uncropped immunoblots can be found in Supplementary Fig. 21.

LysotrackerTM staining observed over 12 h (Fig. S18f, g). We
concluded that HT3 cell lines were resistant to canonical NLRP3
inﬂammasome activation, but could undergo GSDME-induced
pyroptosis in response to Hla92. Although HT3B3-KO cell lines
appeared to be more susceptible than HT3B3-WT cells to this form
of pyroptosis, death did not involve lysoptosis.

Non-canonical inﬂammasome activation by cytoplasmic LPS is
commonly activated by direct activation of CASP4/5 in human
epithelial cells leading to GSDMD-mediated pyroptosis93. HT3B3-WT
and HT3B3-KO cell lines were exposed to cytoplasmic LPS by
nucleofection93,94. These lines showed comparable amounts of cell
death based on SG uptake, and death was blocked by the CASP1
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inhibitor, VX765, but not E64d (Fig. 10a). By immunoblotting,
GSDMD, but not GSDME, N-terminal domains were detected
~1 h after nucleofection (Fig. 10b). There was no difference in the
TEM morphology of HT3B3-WT and HT3B3-KO cell lines dying by
this form of pyroptosis (Fig. S19). While the lack of protection
from E64d, suggested that increased cytosolic cysteine peptidase
activity did not contribute to GSDMD-mediated pyroptosis, to
12

directly assess LMP, we examined the cells lysosomal content by
ﬂow cytometry using the metachromatic dye, acridine orange
(AO)95. To conﬁrm that AO could detect LMP by ﬂow cytometry,
HT3B3-WT and HT3B3-KO cells were resuspended in a medium
containing the lysosomal destabilizing compound, L-leucyl-Lleucine methyl ester (LLOMe)96,97. Confocal imaging of adherent
HT3B3-WT cells showed that LMP could be detected early after

COMMUNICATIONS BIOLOGY | (2022)5:47 | https://doi.org/10.1038/s42003-021-02953-x | www.nature.com/commsbio

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02953-x

ARTICLE

Fig. 6 Tumor epithelial cell lines null for SERPINB3 undergo lysoptosis-like death when exposed to the apoptosis inducer, staurosporine. a HT3B3-WT
or HT3B3-KO cells were pretreated with DMSO, 10 µM DEVD-CHO (DEVD), or E64 for 1 h prior to treatment with DMSO or 10 µM staurosporine (STS) in the
presence of NucView caspase-3/7 activity detection reagent for 16 h (% caspase-3/7 positive = (#Nucview positive/# of nuclei) × 100), (Note, this caspase
data was performed in conjunction with the Sytox staining shown in q). b Immunoblot analysis of PARP, cleaved PARP (cPARP), caspase-3 cleavage, and actin
(α-act) in HT3B3-WT or HT3B3-KO cell lines treated with DMSO (-) or 10 µM STS (+). The dashed area is shown with contrast enhancement below (black
arrowheads = full length, open arrowheads = cleavage product). c–n Representative confocal images (scale bar = 25 µm) of HT3B3-WT or HT3B3-KO cells
treated with DMSO or 10 µM STS for 18 h and then stained with H33342 (blue), annexin V (green), and PI (red). o, p Quantiﬁcation of the percent annexin V
and PI-positive cells from n ≥ 10 ﬁelds shown in (c–n). q HT3B3-WT or HT3B3-KO cells were treated as in (a) and incubated with Sytox™ orange for 16 h
(percent dead = (# of Sytox™ positive/# of nuclei) × 100). r–u To quantify lysosomal content, HT3B3-WT or HT3B3-KO cells were incubated with ﬂuorescently
labeled different molecular weight dextrans as above, prior to exposure to DMSO or 10 µM STS. Live-cell confocal microscopy was used to determine the
number of lysosomes at each time point (LCt) normalized to the initial lysosome count at time zero (LCt0) over n ≥ 9 ﬁelds. v AUC for each dextran over time
for the experiment in r–u (means compared using two-way ANOVA with Tukey’s multiple comparisons test). w–z Representative TEM images (scale
bars = 500 nm) of HT3B3-WT or HT3B3-KO cells treated with DMSO or 10 µM STS for 16 h. Apoptotic morphology indicated with open (membrane budding)
and closed arrows (chromatin fragmentation), and necrotic morphology (vacuolization, cytoplasmic clearing) by an asterisk. Unless otherwise noted, a
representative of ≥3 replicates is shown, and the means ± SD were compared using a two-tailed t-test (ns not signiﬁcant, ***P < 0.001). Original imaging data
ﬁles can be found at https://data.mendeley.com/datasets/6g2typdf63/1. Uncropped immunoblots can be found in Supplementary Fig. 21.

LLOMe treatment, with complete loss of lysosomal staining by
240 min with all of the cells dying, as indicated by Sytox™ Red
uptake (Fig. S20). Flow cytometry using AO and Sytox™ Blue,
followed a similar pattern (Fig. 9c, e, f). Both HT3B3-WT and
HT3B3-KO exposed to 5 mM LLOMe showed that lysosomal
staining in live cells (lysosome+-live cells; Quadrant 1 (Q1);
Fig. 10c, e, f) decreased over time. This decrease was associated
with an increase in lysosome−-live cells at 20 min (Q4; Fig. 10c, e,
f). By 120 min, the percent of lysosome−-live cells decreased (Q4;
Fig. 10c, e, f). As expected, there was a progressive increase in
lysosome−-dead cells over time (Q3; Fig. 10c, e, f). To summarize
(purple arrow, Fig. 10e), most of the cells were lysosome+-live
cells at 20 min into the experiment (Q1 in Fig. 10c, e, f). With
LLOMe treatment, cells shifted to the lysosome−-live-cell
compartment (Q4 in Fig. 10c, e, f), and then to the lysosome
−-dead-cell compartment over time (Q3 in Fig. 10c, e, f). Very few
cells were detected in the lysosome+-dead cell compartment
(<2%), even after 120 min of LLOMe treatment (Q2 in Fig. 10c, e,
f). We concluded that LMP occurred prior to cell death after
treatment with LLOMe and ﬂow cytometry could be utilized to
study the relationship of LMP to cytoplasmic LPS-induced
pyroptosis in these tumor cell lines. Treatment with LPS via
nucleofection yielded a different ﬂow-cytometry pattern over time
(green arrow, Fig. 10e). Induction of pyroptosis by LPS resulted in
the emergence of a lysosome+-dead-cells and not a lysosome
−-live-cell population (compare Q2 vs. Q4 in Fig. 10d, e, g).
Ultimately, lysosome+-dead-cells were lost, and only lysosome
−-dead cells were detected (Q3 in Fig.10d, e, g). Taken together,
we concluded that non-canonical inﬂammasome activation leads
to GSDMD-mediated pyroptosis in these tumor cell lines.
However, detectable LMP was mostly a postmortem event and
explained why the loss of SERPINB3 did not increase the
susceptibility of HT3 cells to death induced by either GSDMD or
GSDME N-terminal domains.
Discussion
Since Christian De Duve’s discovery of lysosomes in 1955, there
has been a long-standing debate on whether LMP and the displacement of lysosomal hydrolases into the cytosol compromise
cell survival or serve as the prelude to postmortem autolysis28.
While data suggest that LMP contributes to the cytopathic
changes associated with many RCD pathways, death is not
lysosomal-dependent unless the cells are treated harshly or
exposed to lysosomotropic detergents that disrupt lysosomal
membranes1. These observations support the notion that LMP

and lysosomal hydrolases are conscripted by other cell death
routines to augment their killing, but LDCD per se does not
signify the action of a molecularly deﬁned, stand-alone RCD
pathway analogous to others described1. Previously, we characterized a form of LDCD in C. elegans that challenges this
hypothesis41. Since the necroptosis and pyroptosis pathways are
not conserved in C. elegans, and neither apoptosis nor entosis are
active in the adult soma, this virulent cell death phenotype
represents a clear example of a stand-alone LDCD pathway in
metazoans41,47,98. We designated this cell death process “lysoptosis” to distinguish it from those forms of LDCD that are not
negatively regulated by cytoplasmic serpins (e.g., SRP-6 or other
types of protease inhibitors), and whose attributes are limited
only to the detection of LMP and cathepsin activity1.
The objective of this study was to determine whether lysoptosis
was evolutionarily conserved in higher eukaryotes by identifying
its presence among the more commonly described RCD pathways. Since mSerpinb3a (mouse) and SERPINB3 (human) are
orthologous intracellular/Clade B lysosomal cysteine peptidase
inhibitors homologous to C. elegans srp-6, we used a similar
genetic loss-of-function strategy to enhance the detection of
lysoptosis in mice and human cell lines.
As in C. elegans, intestinal cultures derived from mSerpinb3a−/−
mice were more sensitive to hypoosmotic stress, compared to those
from mSerpinb3a+/+ mice. The killing kinetics were rapid, with
the majority of cells dying within 30 min of exposure. The FIECs
showed extensive LMP prior to plasma membrane permeabilization and demonstrated the necrotic features that were similar to
those of srp-6(-) C. elegans41. Cell death was inhibited by E64d, and
there was no evidence of apoptosis or necroptosis. Similarly, the
human squamous cell cancer lines null for SERPINB3 were more
sensitive than controls upon exposure to hypotonic stress. Moreover, assessment of LMP by the release of ﬂuorescently labeled
dextrans in the HT3B3-KO cells phenocopied that observed in the
C. elegans srp-6(-) intestinal cells. This response was blunted in
wild-type animals and cells, which attests to the role of the
intracellular serpins in moderating LMP and lysoptosis-induced
cell death. Analysis of the lysosomal cysteine proteases in the
human cervical cancer cell lines indicated that this lysoptosis-like
death resulted in the release of active CTSL into the cytoplasm of
SW756B3-KO cells. Genetic or pharmacologic reduction of CTSL
activity resulted in signiﬁcant protection of the cells to hypotonic
stress. This result suggested that, as in the C. elegans model41,
CTSL is one of the major cysteine proteases involved in the
lysoptosis pathway in mammalian cells. However, additional studies in different cell types and/or organisms are required to
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determine whether other types of CTSs also play a prominent role
in cell-speciﬁc lysoptosis cell death routines.
One means to study evolutionary conservation of function is to
express mammalian proteins in more primitive loss-of-function
models and assess for transgenic rescue. Several of the mammalian intracellular serpins including human SERPINB3 and -B13,
as well as mSerpinb3a possess lysosomal cysteine protease
14

inhibitory activity in vitro50,65,70. SERPINB3 and -b3a expressing
transgenic srp-6(-) C. elegans showed protection against
hypoosmotic stress, suggesting that these serpins replaced the
function of SRP-6 in C. elegans. Additionally, the A341R (P14)
mutation of SERPINB3, which blocks serpin protease inhibition,
suppressed the rescue50. Of note, SERPINB3, but not SERPINB3A341R, was also found to protect the human HT3B3-KO. These
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Fig. 7 Initiation of mTP-dependent necrosis by H2O2 triggered lysoptosis-like death in HT3B3-KO cells. a–n Representative live-cell confocal images of
HT3B3-WT and HT3B3-KO cells stained with JC-1, then treated with 5 mM H2O2. Images were collected using Ex 488 nm with detection windows of Em
498–532 nm (JC-1 monomer, green) and 566–606 nm (JC-1 oligomer, red) every 5 min over 3 h (select time points shown). m Fluorescence intensity of
JC-1 oligomer/JC-1 monomer normalized to time 0 (rel. JC-1 oligomer/JC-1 monomer) of the experiment in panels a–n. Time points with no ﬂuorescence in
either channel (dead cells) were eliminated from the analysis. n Area under the curve (AUC) for multiple ﬁelds for experiment in panels a–n (compared
using one-way ANOVA with Tukey multiple comparisons). o Percent dead ((#Sytox™ positive/# of nuclei) × 100) of HT3B3-WT or HT3B3-KO cells treated
with 5 mM H2O2 or DPBS for 4 h. p Percent dead HT3B3-WT or HT3B3-KO cells pretreated with DMSO, 10 µM cyclosporin A (CsA), or E64d for 1 h prior to
exposure to 5 mM H2O2 or DPBS for 4 h. q–t To quantify lysosomal content, HT3B3-WT or HT3B3-KO cells were incubated with ﬂuorescently labeled
different molecular weight dextrans as above and imaged using live-cell confocal microscopy. The number of lysosomes at each time point (LCt) were
normalized to the lysosome count at time zero (LCt0). u AUC for each dextran over time for an experiment in q–t (compared by two-way ANOVA with
Tukey’s multiple comparisons test). v–y Representative TEM images (scale bars = 2 µm) of HT3B3-WT or HT3B3-KO cells treated with DPBS or 5 mM H2O2
for 4 h. Insets show normal or abnormal mitochondria (open and dark arrowheads, respectively; scale bars = 500 nm). Yellow arrowheads indicate
enlarged vesicle and cytoplasmic clearing. (z-aa) Quantiﬁcation of TEM images from the experiment in v–y showing the number of necrotic cells per ﬁeld
(z) and abnormal mitochondria per ﬁeld (aa) (≥5 ﬁelds). Unless otherwise noted, a representative of ≥3 replicates is shown, and the means ± SD were
compared using a two-tailed t-test (ns not signiﬁcant, ***P < 0.001, **P < 0.01, *P < 0.05). Original data ﬁles can be found at https://data.mendeley.com/
datasets/tpp7xnmwxg/1.

results conﬁrmed that the protease inhibitory activity of SERPINB3 was required to block lysoptosis. SERPINB4, which inhibits cathepsin G and to a lesser extent, lysosomal cysteine
proteases, also rescued the hypoosmotic stress lethality. We did
not determine if the decreased activity of SERPINB4 in this
system was due to its inhibitory proﬁle or the high levels of
protein expression51. However, both SERPINB1 and -B6 are
inhibitors of cathepsin G99, but they did not protect the srp-6(-)
animals, suggesting the serine protease inhibitory activity of these
serpins was not required. Moreover, the expression of SERPINB4
in the human HT3B3-KO cell line did not rescue the loss of
SERPINB3 against hypotonic stress in these cells. Taken together,
these data suggest that SERPINB4 does not afford protection.
SERPINB13 is another Clade B member that inhibits lysosomal
cysteine proteases65. This serpin also did not suppress the
hypoosmotic stress phenotype in C. elegans, potentially due to the
mosaic nature of the expression patterns associated with the use
of extrachromosomal arrays, or that this serpin neutralizes
nematode cysteine peptidase with a lower second-order rate
constant than that of SERPINB3 or mSerpinb3a70,100. We concluded that mammalian intracellular serpins demonstrated the
ability to impair lysoptosis in C. elegans, which suggested that this
function has been conserved evolutionarily in vertebrates.
Plants, which lack caspases and cannot undergo apoptosis,
undergo a limited number of RCD pathways relative to their
mammalian counterparts101. Vacuolar-mediated cell death
(VCMD) is triggered by the loss of tonoplast (the membrane
surrounding the central vacuole) integrity, the release of vacuolar
proteases into the cytosol, and extensive destruction of the plant
cell. In Arabidopsis thaliana, the release of the vacuolar papainlike cysteine protease, RD21, into the cytosol mediates VCMD102.
RD21 is neutralized by AtSerpin1 and overexpression or loss-offunction of this serpin enhances or protects against cell death,
respectively102. AtSerpin1 is an intracellular serpin with a high
degree of amino acid sequence homology with that of the human
clade B serpins, including SERPINB3103. VCMD, the major RCD
in plants, is analogous to lysoptosis pathway in animals and
underscores the long evolutionary history of this cell death program, which may date back to the origins of Eukaryota over
~1000 Ma104.
We detected low-level lysoptosis in wild-type C. elegans
intestinal cells, mouse FIECs, and human squamous cell carcinoma cell lines in response to hypotonic stress. However, the
phenotype was markedly exacerbated by the loss of srp-6, mSerpinb3a, and SERPINB3, respectively. This observation prompted
us to determine whether limited LMP or the more extreme
lysoptosis was active in other RCD pathways. Endolysosomal

staining remained relatively intact in FIECs from wild-type animals induced to undergo apoptosis or necroptosis. In contrast,
mSerpinb3a−/− FIECs demonstrated a complete loss of endolysosomal staining followed by the breakdown of plasma membrane integrity. Thus, in the absence of mSerpinb3a, necroptosis
and apoptosis inducers activated lysoptosis. Since the FIECs are a
fastidious system, we turned to human tumor cell lines null for
SERPINB3 to determine whether the predominance of lysoptosis
was reproducible even after appropriate activation of another
RCD. Indeed, HT3B3-WT cells exposed to STS showed both biochemical and morphological features of apoptosis. In contrast,
HT3B3-KO cells showed a dramatic increase in LMP and a
lysoptosis-like phenotype despite executioner caspase activation
and PARP cleavage. Moreover, death proceeded in the presence
of DEVD-CHO and could only be blocked by a papain-like
cysteine protease inhibitor. Similarly, wild-type cells died in
response to the necroptosis or MPT-DN pathway-speciﬁc inducers and were blocked by pathway-speciﬁc inhibitors. In contrast,
SERPINB3 null cells showed evidence of necroptosis and MPTdriven necrosis activation (RIPK1 phosphorylation and JC-1
mitochondrial leakage, respectively). However, LMP was accentuated, and the cells exhibited extensive necrotic features consistent with lysoptosis. In both cases, death could only be
prevented by E64d. The association of three RCD pathways;
apoptosis, necroptosis, and MPT-DN, with LMP, suggested that
there is an important biological link between these events. When
we examined LMP using lysosomes loaded with 3–70 kDa
ﬂuorescently labeled dextrans, a different graded pattern of
release was detected between HT3B3-WT and HT3B3-KO cells.
Wild-type cells showed a graded, slower rate of release of the
ﬂuorescently labeled dextran, particularly with the lower molecular mass species (3 kDa » 10 kDa). In contrast, the SERPINB3
null cells showed a similar ordered response, but the release was
more rapid and always included the higher molecular weight
species. Taken together, we concluded that apoptosis, necroptosis,
and MPT-DN generated a limited degree of LMP that permitted
the release of divalent cations and/or <10 kDa molecular mass
species and possibly marginal amounts of proteolytic enzymes.
Thus, these lower molecular mass species may serve as more
important co-factors in the activation of these RCD pathways;
with lysosomal cysteine proteases merely occupying a secondary
role in the disintegration phases of dying or dead cells. However,
in the absence of SERPINB3 or other cytoplasmic cysteine proteinase inhibitors (e.g., cystatins), we hypothesize that the cytosolic release of even trivial amounts of lysosomal cysteine
peptidases may allow for the promiscuous catalysis of lysosomal
integral membrane proteins from the cytoplasmic face of the
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organelle, analogous to the cleavage of the lysosomal integral
membrane protein, LAMP2, by calpains105. In turn, this catalysis
could accentuate LMP, and lead to a feedback loop triggering the
explosive propagation and disruption of the endolysosomal compartment. A positive feedback loop involving a protease-mediated
mechanism could explain the rapid and volatile nature of lysoptosis
also induced by other noxious stimuli (e.g., lysosomotropic
16

detergents, excessive free radicals) and the vacuolated necrotic
morphology commonly observed in these cells106. Other possibilities include the sequential occlusion or destruction of amino acid
export channels, generation of an intraluminal hyperosmolar state,
inﬂux of ﬂuid, and organellar swelling and disruption.
Unlike the other forms of RCD, neither pyroptosis nor ferroptosis co-activated lysoptosis in the absence of SERPINB3.
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Fig. 8 Erastin induces ferroptosis, but minimal LMP, in SW756B3-WT and SW756B3-KO cells. a–d Representative confocal images (scale bar = 25 µm) of
SW756B3 WT or SW756B3 KO cells treated with DMSO or 20 µM erastin for 12 h in the presence of Sytox™ Orange (red, open arrowheads), then stained with the
ROS indicator, H2-DCFDA (green, white arrowheads) and Mitotracker™ Deep Red (white). e Quantiﬁcation of the percentage of H2-DCFDA positive cells in
SW756B3 WT or SW756B3 KO cells after treatment with DMSO (−) or 20 µM erastin (+) for 12 h (means were compared using a one-way ANOVA with Tukey’s
multiple comparisons). f The percent dead 12 h after treatment with erastin ((# Sytox positive nuclei/# blue nuclei) × 100, means compared using a one-way
ANOVA with Tukey’s multiple comparisons). g SW756B3 WT or SW756B3 KO cells were incubated for 1 h with DMSO (−), ferrostatin-1 (fer-1), or E64d, prior to
addition of DMSO (−) or 20 µM erastin (+) for 12 h (% dead and statistical comparison calculated as in panel f). h–k Representative confocal images (scale
bar = 25 µm) of SW756B3 WT or SW756B3 KO cells treated with DMSO or 20 µM erastin for 12 h and stained with Lysotracker™ Red. l Quantiﬁcation of the
lysosomal count per cellular µm2 (≥6 ﬁelds). m–p SW756B3 WT or SW756B3 KO cells were incubated with ﬂuorescently labeled different molecular weight
dextrans as above prior to exposure to either DMSO or 20 µM erastin and imaged using live-cell confocal microscopy. The number of lysosomes were quantiﬁed
as above. q Area under the curve (AUC) for each dextran over time. (two-way ANOVA with Tukey’s multiple comparisons test). r–u Representative TEM images
(scale bars = 2 µm) of SW756B3 WT or SW756B3 KO cells treated with either DMSO or erastin for 12 h. Insets show normal and abnormally appearing
mitochondria (open and black arrowheads, respectively; scale bars = 500 nm). v, w Quantiﬁcation of the number of abnormal mitochondria (v) and necrotic cells
(w) in the experiment in panels r–u (≥10 ﬁelds). The means ± SD were compared using a two-tailed t-test (ns not signiﬁcant, ***P < 0.001, **P < 0.01, *P < 0.05).
Original data can be found at https://data.mendeley.com/datasets/9m9f4cfhxy/1.

However, we were unable to detect caspase-1 and GSDMD
cleavage using the canonical NLRP3 pyroptosis inducer, nigericin,
in the HT3 cell lines. Moreover, Hla-induced GSDME cleavage,
not GSDMD in the HT3 cell lines, indicative of CASP3
activation91. We could detect GSDMD-mediated pyroptosis in
cells activated by the non-canonical pathway, in which electroporated LPS directly activates caspase-4/593,107,108. Under these
conditions, little LMP occurred antemortem with most of the
LMP occurring after the loss of plasma membrane integrity.
These data suggested that pyroptosis neither required nor triggered extensive LMP in the HT3 cell lines.
The original description of ferroptosis did not ascribe a role for
LMP, and death was not blocked by E64d77. Subsequently, a role
for the lysosome in generating Fe(II) for Fenton-type reactions
leading to lipid peroxidation have been recognized10,79. We were
unable to detect any evidence of increased LMP after induction of
ferroptosis in wild-type cancer cells. In the absence of SERPINB3,
there was lysosomal leakage of the 3–10 kDa dextran species.
However, cell death was not enhanced, and E64d, unlike fer-1,
had no protective effect. We concluded that lysoptosis was not
activated by the induction of ferroptosis.
Although the mSerpinb3a−/− FIECs were more susceptible to
lysoptosis, the effects of serpin loss and predisposition to LMP had
not been assessed comprehensively in vivo. In a mouse model
system, M. tuberculosis-infected macrophages are more susceptible
to protease-induced death in mSerpinb3a−/− animals109. Also,
SERPINB3 transgenic overexpression protects bax−/− bak−/−
baby mouse kidney cells from the damaging effects of LMP110.
Since the discovery of the SERPINB3 (a.k.a. squamous cell carcinoma antigen (SCCA)) in 1977, numerous clinical reports show
that elevated circulating levels of this protein are a poor prognostic
factor for patients with advanced squamous cell carcinomas and
other epithelial malignancies111,112. We hypothesize that tumor cells
with increased expression of this cytoprotective serpin are afforded a
distinct survival advantage113. We recently reported that high circulating levels of SERPINB3 are also an early indicator of a poor
response to chemoradiation therapy in patients with cervical squamous cell carcinomas61. Moreover, as we show in a companion
paper to this study, the HT3B3-KO and SW756B3-KO cell lines
demonstrated enhanced sensitivity and a lysoptosis-like cell death
phenotype in response to irradiation in vitro and in vivo114. These
clinical observations raise the intriguing possibility of exploiting the
discovery of small-molecule inhibitors that incapacitate speciﬁc
serpins to enhance the response of SERPINB3-expressing tumor
cells to cancer therapeutics, irradiation, or lysoptosis inducers. Taken
together, these studies provide evidence that SERPINB3/mSerpinb3a
are cytoprotective in vivo.

The role of SERPINB3 as a pro-survival factor that protects
against the toxicity of lysosomal proteases can be extended to
other members of the intracellular/clade B serpin family. SERPINB1 is highly expressed in the myelocytic lineage and neutralizes neutrophil granule proteases including cathepsin G,
neutrophil elastase, and proteinase 3115. Neutrophils from SERPINB1 null mice are markedly susceptible to LLOMe as compared to wild-type, and death could be suppressed by genetic loss
of cathepsin G, but not by incubation with caspase inhibitors116.
SERPINB9 is a potent inhibitor of granzyme B (GZMB), which is
stored in the lytic granules (lysosome-related organelles) of
CD8 + cytotoxic T cells (CTLs), regulatory T cells, and natural
killer (NK) cells117. SERPINB9 has a pro-survival function in
CTLs and NK cells by blocking activation-induced cell death,
which is induced by GZMB leakage from lytic granules118–120.
In the 1963 Ciba symposium, the role of lysosomes as “suicide
bags” that participated in physiological involutions was
proposed121. By 1983, this concept “waned considerably…as it
proved difﬁcult to distinguish clearly between the actual rupture
of lysosomes and their mere fragilization…and between premortal injuries to the lysosomes, possibly causal of cell death, and
postmortem alterations that would be no more than a consequence of cell death28.” We suggest that over half a century
later, Christian de Duve and his detractors were both correct.
Methods

C. elegans growth and maintenance. All C. elegans strains were grown and
maintained using standard procedures122. Both the wild-type N2 Bristol strain and
mutant srp-6(ok319) were grown at 20–25 °C on standard nematode growth
medium (NGM) plates seeded with E. coli OP50 as the food source41.

C. elegans plasmid construction. The Psrp-6mammalianSERPINcDNA::GFP plasmids were constructed by ﬁrst amplifying the srp-6 promoter from N2 genomic
DNA using primers that contained SphI restriction sites (Forward: 5′-CGCGCA
TGCGGTCTCAACCACCTTTTCCTCCGC-3′; Reverse: 5′- GCGGCATGCCGA
AATTGAAGAAAAGTGTTCAC-3′) and ligated into the SphI restriction site of
pPD95.77, which contains GFP DNA and the unc-54 3′ UTR, to make the Psrp123. The cDNA sequences for the mammalian serpins were ampliﬁed using
6GFP
the following primer sets: SERPINB3 (Forward: 5′-GGGGTCGACAAAAAT
GAATTCACTCAGTGAAGCC-3′; Reverse: 5′-TTGGATCCCGGGGATGAGAAT
CTGCC-3′), SERPINB4 (Forward: 5′- GGGGTCGACAAAAATGAATTCACTCA
GTGAAGCC-3′; Reverse: 5′-TTGGATCCTGGGGATGAGAATCTGCC-3′), Serpinb3a (Forward: 5′-GTCAGTCGACAAAAATGCATTTGTTTGCTGAAGCCA
C-3′; Reverse: 5′- ATGGATCCAGGGGAGGAGATTCTGCC-3′), SERPINB1
(Forward: 5′-CCTTCTGCAGAAAAATGGAGCGCTGAGC-3′; Reverse: 5′-AAG
CGGATCCTCTAAGGGGAAGAAAATCTCCC-3′), SERPINB6 (Forward: 5′-ATC
GGTCGACAAAAATGGATGTTCTC-3′; Reverse: 5′-CCCGGAGAGGAAAAGC
GG-3′), SERPINB13 (Forward: 5′- GTCAGTCGACAAAAATGGATTCACTTGG
CGCCG-3′; Reverse: 5′-ATGGATCCAGGAGAAGAAAATCTGCCGAAG-3′).
SERPINB3, -B4, -B3a, and –B13 were ligated into the SalI-BamHI restriction
enzyme sites of Psrp-6GFP, SERPINB1 was ligated into the PstI-BamHI restriction
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enzyme sites of Psrp-6GFP and SERPINB6 was ligated into the SalI-SmaI restriction
enzyme sites of Psrp-6GFP to create the plasmids Psrp-6SERPINB3 cDNA::GFP, PsrpcDNA::GFP, P
cDNA::GFP, P
cDNA::GFP, P
srp-6Serpinb3a
srp-6SERPINB1
srp6SERPINB4
cDNA::GFP and P
cDNA::GFP. A P14 mutation (V341R)
6SERPINB6
srp-6SERPINB13
was generated in Psrp-6SERPINB3::GFP construct using the Quikchange™ site
directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) with the primers
forward: 5′-GGTTACAGAGGAGGGACGAGAAGCTGCAGCTGCC-3′; reverse:
5′-GGCAGCTGCAGCTTCTCGTCCCTCCTCTGTAACC-3′ per manufacturer’s
18

instructions to generate the Psrp-6SERPINB3(V341R) cDNA::GFP construct. All
plasmid sequences were conﬁrmed by Sanger sequencing.
C. elegans transgenic strain generation. The gonads of adult srp-6(ok319)
mutant C. elegans were injected with 50 ng/µl of the individual Psrp-6mammalianSERPIN::GFP construct plus 10 ng/µl of the co-injection marker Pmyo-2mCherry
and 40 ng/µl of pBluescript SK(-) ﬁller DNA to create the following lines: VK1276
(srp-6(ok319);vkEx1276[Psrp-6SERPINB3cDNA::GFP; Pmyo-2mCherry]), VK1279 (srp-
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Fig. 9 Tumor epithelial cell lines null for SERPINB3 undergo lysoptosis-like death under conditions that induce RIP1K-dependent necroptosis. a Percent
dead ((# Sytox positive nuclei/# of blue nuclei) × 100) of HT3B3-WT or HT3B3-KO cells 12 h after incubation with DMSO or 10 ng/µL human TNFα + 0.1 µM
BV6 SMAC mimetic + 0.5 µM qVD-OPh + 1 µM cyclohexamide (T + S + Q + C). b Percent dead (calculated as in panel a) of HT3B3-WT or HT3B3-KO cells
incubated with DMSO, 50 µM nec-1 or 10 µM E64d for 1 h prior to exposure to T + S + Q + C for 8 h. c Immunoblot analysis of RIP kinase 1 (α-RIPK1),
phosphorylated RIP kinase 1 (α-pRIPK1), and actin (α-act) in HT29 (control cell line), HT3B3-WT, and HT3B3-KO treated with DMSO (−) or T + S + Q + C
(+) for 12 h (black arrowheads denote bands for RIPK1 and pRIPK1 based on molecular mass). d–g Representative confocal images (scale bar = 25 µm) of
HT3B3-WT or HT3B3-KO cells incubated with DMSO or T + S + Q + C and stained with Lysotracker Deep Red (white). h Quantiﬁcation of the lysosomal
count per cellular µm2 for the experiment in d–g (≥9 ﬁelds, compared using a one-way ANOVA with Tukey’s multiple comparisons). i–l To quantitate
lysosomal content, HT3B3-WT or HT3B3-KO cells were incubated with 3 kDa Cascade blue, 10 kDa Alexa488, 40 kDa TMR, and 70 kDa Texas red labeled
dextrans prior to exposure to either DMSO or T + S + Q + C and imaged using live-cell resonance scanning confocal microscopy (≥20 z-planes, ≥10
ﬁelds). The number of lysosomes at each time point (LCt) were normalized to the lysosome count at time zero (LCt0). m AUC for each dextran over time
for an experiment in i–l (two-way ANOVA with Tukey’s multiple comparisons test). n–q Representative TEM images (scale bars = 2 µm) of HT3B3-WT or
HT3B3-KO cells treated with DMSO or T + S + Q + C. r Quantiﬁcation of the number of necrotic cells per ﬁeld (≥10 ﬁelds) for the experiment in n–q. Unless
otherwise noted, a representative of ≥3 replicates is shown, and the presented means ± SD were compared using a two-tailed t-test (ns not signiﬁcant,
***P < 0.001, **P < 0.01, *P < 0.05). Original imaging data can be found at https://data.mendeley.com/datasets/gvgnvkw4ct/1. Uncropped immunoblots
can be found in Supplementary Fig. 21.

6(ok319);vkEx1279[Psrp-6SERPINB4cDNA::GFP; Pmyo-2mCherry]), VK1282 (srp6(ok319);vkEx1282[Psrp-6Serpinb3acDNA::GFP; Pmyo-2mCherry]), VK2649 (srp6(ok319);vkEx2649[Psrp-6SERPINB1cDNA::GFP; Pmyo-2mCherry]), VK2651 (srp6(ok319);vkEx2651[Psrp-6SERPINB6cDNA::GFP; Pmyo-2mCherry]), VK2653 (srp6(ok319);vkEx2653[Psrp-6SERPINB13cDNA::GFP; Pmyo-2mCherry]) and VK1277 (srp6(ok319);vkEx1276[Psrp-6SERPINB3(A341R)cDNA::GFP; Pmyo-2mCherry]).

SERPINB3 knockout cell line production and characterization. HT3B3-KO and
SW756B3-KO cell lines were generated as previously described in ref. 61. In brief, the
LentiCRISPR V2 (Addgene 52961, Addgene, Watertown, MA, USA) lentiviral
vector containing hSpCas9 and either an empty sgRNA cassette (CRISPR-control
cells) or a guide RNA targeting exon 5 of SERPINB3 gene was designed using
standard cloning procedures. Lentivirus was packaged in HEK293T cells, concentrated using Lenti-X Concentrator (Clontech, Mountain View, CA, USA), and
used to infect HT3 and SW756 parental cells (ATCC©) with polybrene for 24–48 h.
Pools were selected with puromycin and single cell clones obtained through ﬂow
sorting into 96-well dishes. Target locus KO was conﬁrmed in selected clones by
targeted sequencing of the genomic locus, mRNA using qRT-PCR, and protein
levels with Western blot (Fig. S5). For CRISPR-control cells, the puromycinselected pool was used. Genomic DNA was isolated from cells using DNeasy Blood
and Tissue Kit (Qiagen, Hilden, Germany), the SERPINB3 locus was ampliﬁed
using PCR (forward primer: ATGGAAGAAAGCAAGGCAGA, reverse primer:
TAAAGGGGAAGGGAGATGCT), and sequenced using Sanger sequencing (Primer: CTTCGGTGACCTCTTTCTTGC). Transcript levels were determined using
qRT-PCR on cDNA isolated from each of the cell lines (forward primer:
CGCGGTCTCGTGCTATCTG, reverse primer: ATCCGAATCCTACTACAGCGG). Western blot analysis was performed on whole-cell lysates with proteinase and phosphatase inhibitors, equal parts protein (25–30 µg) and Laemmli
sample buffer (Santa Cruz Biotechnology) were boiled at 95 degrees Celsius for
10 min and gel electrophoresed on 4–20% gradient gels (Mini-Protean TGX; BioRad), transferred to PVDF blot using the Trans-Blot Turbo Transfer System (BioRad), blocked with 5% milk:TBS-Tween and incubated with 1:4000 anti-SERPINB3/4 antibody (NBP2, Novus International, Saint Louis, MO, USA) or antiSERPINB4 monoclonal antibody (8H11), overnight at four degrees Celsius.
1:100,000 anti-Actin (A5441, Santa Cruz Biotechnology, Dallas, TX, USA) was
incubated for 2 h at room temperature. Anti-mouse or anti-rabbit HRP-conjugated
secondary antibody was used for detection with ECL chemiluminescent reagent
(GE Healthcare Life Sciences), visualized, and quantiﬁed using the Bio-Rad ChemiDoc MP imaging system and Image Lab software (Bio-Rad).

Antibodies. PolyADP-ribose polymerase (PARP) (9542), cleaved PARP (5625),
caspase-3 (14220), cleaved caspase-3 (9664), caspase-8 (4790), cleaved caspase-8
(9748), β-actin (3700), RIP1 (3493), phospho-RIP1 (65746), and anti-rabbit IgG,
HRP-linked secondary antibody (7074) were purchased from Cell Signaling
(Danvers, MA). Gasdermin D domain-containing protein 1 (GSDMDC1) (NBP233422) polyclonal, cathepsin L polyclonal (AF952), and SERPINB3/4 monoclonal
antibodies (NBP2-45788) were purchased from Novus Biologicals (Centennial,
CO). Gasdermin E (GSDME) (ab215191) was purchased from Abcam (Cambridge,
MA). Monoclonal anti-cathepsin B Antibody (H-5; sc-365558) and mouse-IgGκ
BP-HRP-linked secondary antibody (sc-516102) was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). SERPINB3 (8H11), SERPINB4 (10C12) monoclonal antibodies, and SERPINB3/B4 polyclonal were used as previously
described124. All primary antibodies were used at 1:1000, except the SERPINB3/B4
polyclonal, and secondary antibodies were used at 1:2000 dilution.

Cell culture. Normocin (ant-nr-1) and zeocin (ant-zn-1) were purchased from
InvivoGen (San Diego, CA). Fetal bovine serum (FBS), Iscove’s Modiﬁed Dulbecco’s Medium (IMDM) (12440079), Dulbecco’s modiﬁed essential medium
(DMEM) (11965126), RPMI 1640 (11875093), L-glutamine (25030081), OptiMEM™ (31985070), sodium pyruvate (11360070), GlutaMax™ (35050061), Dulbecco’s phosphate-buffered saline (DPBS) without magnesium and calcium
(14190136) and DPBS with magnesium and calcium (14040117) were purchased
from Thermo Fisher Scientiﬁc (Waltham, MA). Penicillin-streptomycin solution
(25-512) and N-2-hydroxyethylpiperazine-N′-2-ethanesulphonic acid (HEPES)
(25-534) were purchased from Genesee Scientiﬁc (El Cajon, CA). StableCell™
trypsin solution (T2610) was purchased from Sigma Aldrich (St. Louis, MO).
Dimethyl sulfoxide (DMSO) (sc-358801) was purchased from Santa Cruz
Biotechnology.
Except where indicated, all cell lines were obtained from the American Type
Culture Collection (ATCC, Manassas, VA). The human squamous cell carcinoma
epithelial cell lines HT3B3-WT, HT3B3-KO, SW756B3-WT, and SW756B3-KO were
generated by CRISPR/Cas9 as previously described61. HT3 derived lines were
maintained in complete IMDM media (containing 15% FBS and 2 mM L-glutamine)
and sub-cultured every 3–5 days. SW756 derived lines were maintained in
complete DMEM media (containing 10% FBS and 2 mM sodium pyruvate) and
sub-cultured every 2–3 days. The CRISPR-generated cell lines were assessed for
authenticity using STR proﬁling (ATCC). The human colorectal adenocarcinoma
epithelial line HT29 (ATCC® HTB-38™) were maintained in complete DMEM
media (containing 10% FBS and 2 mM sodium pyruvate). The cells were subcultured every 3–5 days. The human connective tissue ﬁbrosarcoma epithelial cell
line HT-1080 (ATCC® CCL-121™) were maintained in complete OptiMEM™ media
containing 4% FBS, 20 mM HEPES, and 10 mM GlutaMax™ (Thermo Fisher
Scientiﬁc). The cells were sub-cultured every 1–2 days. The human monocyte cell
line THP1-HMGB1-Lucia™ (thp-gb1lc) was obtained from InvivoGen. The cells
were maintained in complete RPMI 1640 media (containing 10% FBS, 25 mM
HEPES, 2 mM L-Glutamine, 100 µg/ml Normocin, and 100 µg/ml of Zeocin). The
cells were sub-cultured every 2–3 days. All cell lines were cultured at 37 °C in 5%
CO2. Except where indicated, all media contained 100 units/ml penicillin and
100 µg/ml streptomycin.
Cell death inhibitors. Prior to experiments in FIECSs or cell lines, a dose-response
of the different inhibitors was conducted to determine effective concentrations and
toxicity. The pan-cysteine protease inhibitor, E64 or E64d (Bachem, Torrance, CA)
was used at a ﬁnal concentration of 10 µM in human cell lines and 1 µM in FIECS. The
caspase-3/7 inhibitor, DEVD-CHO (BD Biosciences), was used at a ﬁnal concentration of 10 µM in all cultures. The pan-caspase inhibitor, z-VAD-fmk (Enzo
Life Sciences, Farmingdale, NY) was used at a ﬁnal concentration of 10 µM in
human cell lines and 1 µM in FIECS. The RIP1K inhibitor, necrostatin-1 (UBPBio,
Aurora, CO), was used at a ﬁnal concentration of 5 µM in FIECs and 10 µM in human
cell lines. All inhibitors were dissolved in the diluent, in dimethyl sulfoxide
(DMSO). Unless otherwise stated, inhibitors were added to DMEM plus 20% FBS
at 37 °C in 5% CO2 for 1 h prior to induction of death.
Chemicals. (2 S,3 S)-3-[[(2 S)-1-[4-(diaminomethylideneamino)butylamino]-4methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid (E64) (A2576),
ethyl (2 S,3 S)-3-[[(2 S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate (E64d) (A1903), (S,S,2 S,2’S)-N,N’-((2 S,2’S)-(hexane-1,6-diylbis(azanediyl))bis(3-oxo-1,1-diphenylpropane-3,2-diyl))bis(1-((S)-2cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) (BV6) (B4653), and quinolyl-valyl-O-methylaspartyl-[-2, 6-diﬂuorophenoxy]-methyl ketone (Q-VD-OPh hydrate) (A1901) were purchased from
ApexBio (Boston, MA). Staurosporine (STS; J67198) and cyclosporin A (CsA;
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J63191) were purchased from Alfa Aesar (Ward Hill, MA) and TOCRIS Bioscience.
Acetyl-Asp-Glu-Val-Asp-aldehyde (Ac-DEVD-CHO; 556465) was purchased from
BD Biosciences. Z-Val-Ala-Asp (OMe)-CH2F (z-VAD-fmk; 627610), (4-[(2 R)-2[(1 S,3 S,5 S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione
(cycloheximide; CHX; 239765), digitonin (CHR103) and α-hemolysin from Staphylococcus aureus (Hla; H9395) were purchased from Millipore Sigma (St. Louis,
MO). Belnacasan (VX765) (S2228), 2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-quinazolinone (erastin) (S7242), 7-Cl-O5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one (nec-1s)
(S8641), and 3-Amino-4-cyclohexylaminobenzoic acid ethyl ester (ferrostatin-1)
(S7243) were purchased from Selleckchem (Houston, TX). Ammonium iron (III)
20

citrate (FAC) (61221) was purchased from ACROS Organics (Fair Lawn, NJ).
Standard LPS, Escherichia coli K12 (LPS-EK; tlrl-eklps) was purchased from
Invivogen. Tumor Necrosis Factor alpha (TNFα) (300-01 A) was purchased from
Peprotech (Rocky Hill, NJ). H-Leu-Leu-OMe•HBr (LLOMe) (4000725) was purchased from Bachem. Cathepsin L Inhibitor, CAA0225, (21-950-21MG) and
hydrogen peroxide (H2O2) (H325) were purchased from Fisher Scientiﬁc
(Pittsburgh, PA).
Fetal intestinal explant cultures (FIECs). Mouse experiments were approved by
the University of Pittsburgh and Washington University Animal Care and Use
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Fig. 10 Cytosolic LPS induces pyroptosis but not LMP in both HT3B3-WT and HT3B3-KO cell lines. a HT3B3-WT (blue) or HT3B3-KO (red) cells were
subjected to nucleofection (nuc, +) in the absence (−) or presence (+) of 5 ug/ml LPS-EK (LPS), caspase-1 inhibitor, VX765, or lysosomal cysteine
protease inhibitor, E64. An aliquot of cells were also not nucleofected (nuc, −). After 3 h, cells were stained with SG and Hoescht 33342 and imaged.
Quantiﬁcation: (# Sytox positive nuclei/# of blue nuclei) × 100. Means ± SD were compared using a two-tailed t-test (*P < 0.05). b Immunoblot of
gasdermin D (GSDMD) and gasdermin E (GSDME) cleavage in THP1 cells treated with α-hemolysin (HlA); positive control. HT3B3-WT/HT3B3-KO were
nucleofected with 0, 1, or 5 µg of LPS and left to recover for 1 h. Open arrowheads: full-length GSDMD and GSDME based on molecular mass. Black
arrowheads: cleaved GSDMD. Dashed box: area contrast enhanced for clarity. Note, the positive control for GSDME cleavage is provided in Fig. S18b.
c, d Flow cytometry analysis of HT3B3-WT/HT3B3-KO cells treated with a lysosomotropic agent, LLOMe (c) or 1 µg/ml LPS (d). Cells were stained with the
lysosomotropic dye, acridine orange (Y-axis), and the cell viability dye, Sytox™ blue (X-axis). Lines indicate the threshold ﬂuorescence levels (gate) to
determine each quadrant. Numbers indicate cell percentage in each quadrant. e Schematic representation of each quadrant. Quadrant 1 (Q1) contained live
cells positive for lysosomal staining (acridine orange positive, Sytox blue negative). Quadrant 2 (Q2) contained dead cells with positive lysosomal staining
(acridine orange positive, Sytox blue positive). Quadrant 3 (Q3) contained dead cells negative for lysosomal staining (acridine orange negative, Sytox blue
positive). Quadrant 4 (Q4) contained live cells negative for lysosomal staining (acridine orange negative, Sytox blue negative). Arrows indicate the timing
of ﬂuorescence loss for different cell death pathways. If the lysosomal loss occurred prior to plasma membrane permeabilization, then the percentage of
cells will increase from Q1 to Q4 to Q3 over time. If the lysosomal loss occurred after plasma membrane loss, then the percentage of cells will increase
from Q1 to Q2 to Q3 over time. f, g Graphical representation of the average of three separate experiments indicating the percentage of cells treated with
LLOMe (f) or nucleofected LPS (g) in HT3B3-WT (blue) and HT3B3-KO (red) cells. Error bars represent means ± SD. Uncropped immunoblots can be found
in Supplementary Fig. 21.

Committees protocols 12020207 and 19-102, respectively. FIECs were generated as
described in ref. 56. Embryos from timed pregnant wild-type Balb/C females
(mSerpinb3+/+) and Serpinb3a homozygous null (mSerpinb3a−/−) mice were
harvested on day E13.5–E15.5 and the intestines removed57. Fetal intestinal tissue
was cut into ~1 mm sections and then dissected to expose the epithelial layer
(Fig. S2a). Intestinal sections were cultured in 200 µl of Dulbecco’s Modiﬁed Eagle
Medium (DMEM) (Thermo Fisher Scientiﬁc) plus 20% FBS using ﬁbronectin (BD
Biosciences) coated glass bottom 35 mm dishes (MatTek Corporation, Ashland,
MA) at 37 °C in 5% CO2 for 18 h. An additional 2 ml of prewarmed DMEM
(Thermo Fisher Scientiﬁc) plus 20% FBS was added to the dishes, and the FIECs
were cultured at 37 °C in 5% CO2 for a further 7-11 days with daily media changes.
Fluorescent staining reagents. Invitrogen™ H33342 (H3570), propidium iodide
(PI; P3566), Sytox™ blue (S11348), Sytox™ red (S34859), Sytox™ green (S7020),
Sytox™ orange (S11368), Lysotracker™ deep red (L12492), Lysotracker™ red DND99 (L7528), Mitotracker™ red (M22425), Mitotracker™ deep red FM (M22426),
CM-H2-DCFDA (C6827), BODIPY™ 581/591 C11 (D3861), Cascade Blue™ dextran
3 kDa (D7132), Alexa Fluor™ 488 dextran 10 kDa (D22910), tetramethylrhodamine
(TMR) dextrans 40 kDa (D1842) and 70 kDa (D1818), and Texas red labeled
dextrans 3 kDa (D3328), 10 kDa (D1863), 40 kDa (D1829), and 70 kDa (D1864)
were purchased from Thermo Fisher Scientiﬁc. Acridine orange (AO) (40039) and
NucView® 530 (10406) were purchased from Biotium. FITC-annexin V was purchased from Southern Biotech or FITC-annexin V apoptosis detection kit (556547)
was purchased from BD Pharmingen.
Light microscopy. Multi-well plate assays were detected for cell death by staining
with the indicated Sytox™ dyes using a Biotek Cytation 5 multimode imaging plate
reader (Agilent Technologies) ﬁtted with a Biotek BioSpa8 live-cell incubator
(Agilent Technologies) at the indicated excitation and emission wavelengths at
37 °C in 5% CO2. The total number of cells were calculated using either
H33342 staining or high contrast brightﬁeld imaging as described in https://
www.biotek.com/resources/application-notes/live-cell-imaging-of-apoptosis-andnecrosis/ using a 4x high contrast objective. The percentage of dead cells was
calculated as the number of Sytox™ positive cells/the total number of cells × 100
using Biotek Gen5 software (Agilent technologies).
Wideﬁeld ﬂuorescence imaging was performed using a Nikon Eclipse Ti
inverted microscope ﬁtted with DIC optics and either a 20 × 0.5 N.A. air objective
or a 40 × 1.3 N.A. oil objective, using a 100 W halogen ﬂuorescent light source and
DAPI HC HISN Zero Shift, GFP HC HISN Zero Shift, DS Red HC HISN Zero Shift
and CY5 HYQ ﬁlter sets (Nikon Instruments, Inc, Melville, NY). Images were
acquired using a Retiga 2000R camera (Qimaging, Surrey, Canada) and Volocity
software (v6.3.5, Quorum, Canada).
Spinning disk confocal images was performed using a Nikon Eclipse Ti inverted
microscope ﬁtted with a Nipkow spinning disk and 488 nm and 568 nm excitation
laser lines. Images were acquired using a CoolSnap HQ camera (Photometrics,
Tucson, AZ) and NIS elements AR software (Nikon Instruments).
Line scanning confocal images were collected using a Leica SP8 tandem
scanning confocal ﬁtted with 20 × 0.4 N.A. air and 40 × 1.3 N.A. oil objectives
using a 488 nm argon gas laser line and 405, 561, and 633 nm diode laser lines or a
Leica SP8 tandem scanning confocal ﬁtted with 25 × 0.95 N.A. water, 40 × 1.3 N.A.
and 63 × 1.4 N.A. oil objectives, a supercontinuum white light laser and 405 nm
diode laser lines. Live-cell imaging was performed at 37 °C in 5% CO2 using either
a stage top incubator with a lens heater (Tokai Hit, Shizuoka, Japan) or a cage
incubator (OkoLabs, PA). Images were collected by HyD avalanche detectors using

LASX software (Leica Microsystems, Buffalo Grove, IL). All images were visualized
and analyzed using Volocity software (v6.3.5, Quorum) or LASX (v6.3, Leica
Microsystems).
Western blotting. Pierce™ Halt™ protease and phosphatase inhibitor cocktail
(78446), Coomassie Plus (Bradford) assay reagent (23238), and BCA protein assay
kit (23227) was purchased from Thermo Fisher Scientiﬁc. RIPA Buffer (786-490)
was purchased from G-Biosciences (St. Louis, MO). AnykDTM Criterion™ TGX
Stain-Free™ precast gels (5678123, 5678124, and 5678125), 10x Tris/Glycine Buffer
(1610771), 10x tris/glycine/SDS buffer (1610772), Precision Plus Protein™ all blue
prestained protein standard (1610373), Clarity Max™ Western ECL substrate
(1705062), and Clarity™ Western ECL substrate (1705061) were purchased from
Bio-Rad (Hercules, CA). Amersham™ Protran™ 0.2 µm nitrocellulose (106000011)
was purchased from Cytiva (Marlborough, MA). 2-Mercaptoethanol (773648) was
purchased from MP Biomedicals (Irvine, CA). Methanol (A412SK-4) and Tween®
20 (BP337-500) were purchased from Thermo Fisher Scientiﬁc.
For analysis of C. elegans proteins, ~100 transgenic srp-6(ok319);vkEx
[Psrp-6mammalianSERPIN::GFP; Pmyo-2mCherry] C. elegans were placed directly
into 2x Laemmli Sample Buffer (62.5 mM Tris-HCl, pH 6.8, 25% (w/v) glycerol, 2%
SDS, 0.01% bromophenol blue, 355 mM 2-mercaptoethanol; Bio-Rad) and boiled
for 20 min. Samples were centrifuged at 500×g for 2 min and the supernatant
separated by AnyKD™ gradient SDS-PAGE (Bio-Rad) under reducing conditions,
electrotransferred via wet transfer at 100 V in Tris/Glycine with methanol (25 mM
Tris, 192 mM glycine, 20% v/v methanol, pH 8.3) onto nitrocellulose (Cytiva) and
blocked in 5% nonfat milk in TBST (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween®
20, pH 7.5) for 1 h at room temperature or overnight at 4 °C. Proteins were
detected using an anti-GFP polyclonal antibody (1:1000 dilution, Santa Cruz
Biotechnology) and tubulin detected using an anti-tubulin monoclonal antibody
(1:2500 dilution, Santa Cruz Biotechnology) was used as a loading control. The
primary antibody binding was detected with peroxidase-conjugated bovine antimouse or peroxidase-conjugated anti-rabbit secondary antibodies (Santa Cruz
Biotechnology). Signal was detected using Super Signal West Pico
Chemiluminescent Substrate (Thermo Fisher Scientiﬁc) and autoradiography.
For analysis of mammalian cellular proteins, media was aspirated from the
plates and they were rinsed once with DPBS. Plates were placed on ice and the cells
were disrupted by adding RIPA lysis buffer supplemented with Pierce™ Halt™
protease and phosphatase inhibitors for 10 min. Cell lysates were transferred to
microcentrifuge tubes and placed at −80 °C. Thawed samples were centrifuged at
21,000 × g. Supernatants were then transferred to new microcentrifuge tubes and
the protein concentration was determined by Pierce™ BCA assay. Equal amounts of
protein (~30 µg of total protein) were mixed with 2x Laemmli buffer with
2-mercaptoethanol and heated to 100 °C for 5 min. Protein samples were
centrifuged at 15,000 × g for 2 min, analyzed by PAGE, and transferred onto
nitrocellulose (Cytiva) as described above. Nitrocellulose membranes were blocked
in 5% nonfat milk in TBST for 1 h at room temperature or overnight at 4 °C.
Proteins were detected using the speciﬁed primary antibody with the appropriate
secondary antibody at the indicated dilutions and visualized using Clarity
chemiluminescent or Clarity-max chemiluminescent substrate (Bio-Rad) using a
Chemidoc MP (Bio-Rad).
Transmission electron microscopy. Cells were incubated in six-well plates for
3 days. On the day of the experiment, cells were treated with death inducers for the
indicated amount of time. For all cell death assays, except pyroptosis, cells were
detached from the plate, centrifuged at 300×g for 4 min, and ﬁxed in 2%
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paraformaldehyde/2.5% glutaraldehyde (Polysciences Inc., Warrington, PA) in
100 mM sodium cacodylate buffer, pH 7.2 for 1 h at room temperature. Sample
processing was performed by the Washington University School of Medicine
Molecular Microbiology Imaging and Washington University Center for Cellular
Imaging facilities. Samples were washed in sodium cacodylate buffer at room
temperature and post-ﬁxed in 1% osmium tetroxide (Polysciences) for 1 h. Samples
were rinsed in ddH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted
Pella, Inc., Redding, CA) for 1 h. Following several rinses in ddH20, samples were
dehydrated in a graded series of ethanol solutions and embedded in Eponate 12
resin (Ted Pella). Sections were cut with a Leica Ultracut UCT ultramicrotome
(Leica Microsystems), stained with uranyl acetate and lead citrate, and viewed on a
JEOL 1200 EX (JEOL USA, Inc., Peabody, MA) equipped with an AMT
8-megapixel digital camera (Advanced Microscopy Techniques, Woburn, MA) or
JEM-1400 TEM (JEOL USA) equipped with an AMT XR111 high-speed 4k × 2k
pixel phosphor-scintillated 12-bit CCD camera (Advanced Microscopy Techniques). Images were captured using AMT Image Capture Engine software
(Advanced Microscopy Techniques).

Cell death assays
Apoptosis. FIECs were washed twice in ice-cold DPBS, once in cold annexin V
binding buffer. FITC-annexin V was diluted 1:10 in annexin V binding buffer and
incubated with FIECs for 15 min at 4 °C in the dark. Cells were stained with 500 nM
PI and 2 µg/ml H33342 for 5 min in the dark prior to visualization. For necroptosis
assays, FIECs were stained with 500 nM PI and 2 µg/ml H33342 for 5 min in the
dark prior to visualization.
Apoptosis was induced in HT3B3-WT and HT3B3-KO cells using 5 µM STS for 1620 h at 37 °C in 5% CO2. Cell death was measured using 500 nM Sytox™ orange
(Thermo Fisher Scientiﬁc) and imaged on the BioTek Cytation™ 5. Annexin V
staining was measured using the FITC-annexin V apoptosis detection kit (BD
Pharmingen, San Jose, CA) per the manufacturer’s instructions. Cells were imaged
by confocal microscopy. For determination of caspase-3/7 activation, cells were
stained with 1 µM Nucview™ 530 (Biotium, Fremont, CA) and imaged on the
BioTek Cytation™ 5.
Ferroptosis. Cells were stimulated using 1 µM FAC and 10 µM erastin for 10–12 h;
notably, ferroptosis was only able to be induced when the cells were ≤50% conﬂuence. Cell death was measured by 500 nM Sytox™ orange (Thermo Fisher Scientiﬁc) uptake using a Biotek Cytation 5 multimode imaging plate reader. For
measurement of ROS production and mitochondrial function during ferroptosis,
100,000 SW756 cells were seeded into a well of a 35 mm optical-bottom dish. Prior
to imaging, cells were stained with 10 µM H2-DCFDA and 1 µM MitoTracker™ red
(Thermo Fisher Scientiﬁc) for 1 h at 37 °C in 5% CO2. Cells were incubated in their
respective media with 10 µM erastin for 10–12 h in the presence of 5 nM Sytox™ red
(Thermo Fisher Scientiﬁc). Images were collected by line scanning confocal
microscopy.
Hypotonic stress was performed in C. elegans as described in ref. 41. The
experiments were repeated three times and the average percentage recorded.
Statistical signiﬁcance was calculated using a two-tailed t-test.
For cell lines, either 15,000 cells/well were seeded into a Nunc™ optical-bottom
96-well plate (Thermo Fisher Scientiﬁc), 150,000 cells/well were seeded into a 24well plate (Genesee Scientiﬁc), or 250,000 cells seeded into an imaging dish (Cellvis,
Mountain View, CA) ~24 h before prior to assay. For FIECs, the medium was
aspirated and replaced with prewarmed to 37 °C 100% or 10–25% DPBS as
indicated, with magnesium and calcium added for the indicated time points. Assays
performed with or without indicated inhibitors at the designated concentrations
were preincubated in the appropriate medium for 30–60 min prior to the assay.
MPT-DN. Death was induced in HT3B3-WT and HT3B3-KO cells using 1–5 mM
H2O2 for 8 h72. Cell death was measured using 100 nM Sytox™ green imaged on the
BioTek Cytation™ 5 with brightﬁeld and GFP (Ex 488 nm/Em 535 nm) LED cubes.
To measure mitochondrial function, cells were incubated with H2O2 inducers for
16 h. Prior to imaging, cells were incubated for 30 min with 500 nM MitoTracker™
Red and 5 nM Sytox™ red (Thermo Fisher Scientiﬁc) and imaged using confocal
microscopy.
Necroptosis. Death was induced in FIECs by incubation with 1 µM z-VAD-fmk and
1 µM staurosporine (TOCRIS Bioscience) in DMEM plus 20% FBS at 37 °C in 5%
CO2 for 8 h59. FIECs were stained with 500 nM PI and 2 µg/ml H33342 for 5 min in
the dark prior to visualization by confocal microscopy.
RIP1K-dependent necroptosis was induced in HT3B3-WT and HT3B3-KO cells using
by pretreating cells with 100 nM BV6, 500 nM qVD-OPh, and 1 µM cyclohexamide at
37 °C in 5% CO2125. After 1 h incubation, human TNFα was added to a ﬁnal
concentration of 10 ng/ml and incubated for 12–16 h at 37 °C in 5% CO2. Cell death
was measured by uptake of 100 nM Sytox™ green imaged on the BioTek Cytation™ 5.
Pyroptosis. Death was attempted to be induced by treating HT3B3-WT and HT3B3-KO
with either nigericin (4312/10; Tocris Bioscience, Bristol, UK) or α-hemolysin (Hla;
H9395; Millipore Sigma) at 37 °C in 5% CO2 at the indicated concentrations and
time points. Pyroptosis was induced in HT3 cells after detaching them from culture
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plates using trypsin-EDTA. Nucleofection was performed according to the manufacturer’s protocol (Lonza, Valparaiso, IN)94. Approximately 500,000 cells per
treatment were resuspended in 100 µL of supplemented Lonza SE cell line Nucleofector™ solution and nucleofected with 5 µg of LPS-EK using the HeLa protocol on
the Lonza 4D-Nucleofector™ System. Cells were resuspended in 1 ml of OptiMEM™
without antibiotics and incubated in a humidiﬁed tissue culture incubator. At the
indicated times, an aliquot of cells was removed and either measured by ﬂow
cytometry, lysed for subsequent immunoblotting, or ﬁxed for analysis by transmission electron microscopy.

Lysosome content and quantiﬁcation. For single time point measurement of
lysosomes via ﬂuorescent imaging, FIECs, HT3, or SW756 cells/well were seeded
into 35 mm optical-bottom dishes. On the day of the experiment, cells were
incubated in their respective media with their respective death inducers for the
indicated amount of time. After treatment, cells were stained using H33342, Sytox™
dyes (5 nM) and Lysotracker™ deep red (200 nM) were added and incubated for
30 min prior to imaging using light microscopy. Wideﬁeld images were analyzed
for lysosomal area per cell and confocal images were analyzed for lysosomal count
per cellular area using threshold-based object identiﬁcation of the different ﬂuorophores in Volocity quantiﬁcation (v6.3.5, Quorum).
For measurement of lysosomes via ﬂow cytometry, HT3B3-WT and HT3B3-KO
cells were detached using trypsin and treated with the indicated treatment. Cells
were subsequently stained with 200 ng/ml acridine orange and 1 µM Sytox™ blue
(Thermo Fisher Scientiﬁc) for 30 min and then analyzed with a Miltenyi
MACSQuant® Analyzer 10.
For the measurement of lysosomal cysteine protease activity in cell lysates, after
cell growth and indicated treatments, cells were placed on ice and the medium was
aspirated. Cells were then washed with 1 ml of cold DPBS with calcium and
magnesium (Thermo Fisher Scientiﬁc; 14040117) prior to addition of the indicated
concentrations of digitonin (Millipore Sigma; CHR103) diluted in DPBS. Cells were
then incubated on ice for 15 minutes. The digitonin solution was then assayed for
protein and cysteine protease content as described above, or 50 µl of the extract was
then mixed with equal amounts of cathepsin reaction buffer (50 mM sodium
acetate, pH 5.5; 4 mM EDTA, 8 mM dithiothreitol) in a 96 well black-walled
microtiter plate and incubated for 5 minutes at 30 °C. The cysteine protease
substrate, zFR-R110 (Fisher Scientiﬁc; PKCA70710209), was then added to a ﬁnal
concentration of 5 µM and ﬂuorescence intensity was measured using a Varioskan
lux (Thermo Fisher Scientiﬁc) ﬂuorescence plate reader at Ex 498 nm, Em 525 nm
every 30 seconds for 30 minutes. The cysteine proteolytic activity (RFU) over time
was calculated using SkanIT RE software (v4.1; Thermo Scientiﬁc).
Lysosomal membrane permeability measurements using ﬂuorescently labeled
dextrans. The C. elegans protocol was modiﬁed from that described earlier in
refs. 41,126. Young adult N2 or srp-6(ok319) animals (n ≥ 200) were incubated in
PBS containing 1 mg/ml of Texas red labeled dextrans 3, 10, 40, or 70 kDa and
heat-killed OP50 at room temperature overnight in the dark. Animals were washed
once with PBS and then placed onto a seeded NGM plate for 4 h to allow trafﬁcking of the ﬂuorescently labeled dextrans through the endolysosomal system and
to chase the excess dextran from the intestinal lumen. Animals were collected from
the plate in 1 ml of PBS in an Eppendorf tube and allowed to settle at 25 °C for
5–10 min. Animals were washed with 1 ml of ddH2O and allowed to settle again.
Excess ddH2O was aspirated from above the animals with a remaining volume of
50–100 µl. Animals were loaded into an L4-YA vivoChip®-2x (Newormics, Austin,
TX) using a 5 ml syringe. Animals were guided into the microﬂuidic channels using
ddH2O and the automatic function of the vivoCube following the manufacturer’s
instructions (Newormics). Animals (≥10 nematodes) were visualized using a
40×1.3 N.A. PlanApo oil objective on an SP8X tandem scanning confocal microscope at an excitation wavelength of 594 nm and emission detection window of
605–640 nm with a HyD avalanche detector, every 15 min for 4 h over ≥20 zplanes. Images were rendered with LASX and lysosomal ﬂuorescence was analyzed
using Volocity software (v6.3.5, Quorum).
For cell lines, the protocol was adapted from that previously described in
refs. 53,127. Approximately 200,000 HT3B3-WTand HT3B3-KO or SW756B3-WTand
SW756B3-KO cells were seeded into an optical-bottom imaging dish (Cellvis
Mountain View, CA) and incubated at 37 °C in 5% CO2 until ~50–80% conﬂuency.
Cells were treated with 10 µM of each of the following dextrans: 3 kDa Cascade
Blue™ dextran, 10 kDa Alexa Fluor™ 488 dextran, 40 kDa tetramethylrhodamine
(TMR) dextran, and 70 kDa Texas red labeled dextran, for 16 h at 37 °C in 5% CO2.
After labeling, cell lines were washed with 37 °C DPBS and chased for 4 h with the
appropriate medium. Cells were exposed to different cell death inducers were
visualized in XYZ planes over time by live-cell confocal microscopy using a Leica
SP8X confocal microscope ﬁtted with a 63×1.4 N.A. PlanApo oil objective at 37 °C
in 5% CO2. The 3 kDa Cascade Blue™ dextran was excited at 405 nm and the
emission was detected at 420–460 nm, 10 kDa Alexa Fluor™ 488 dextran was
excited at 488 nm and the emission detected at 500–540 nm, 40 kDa TMR dextran
was excited at 561 nm and the emission detected at 570–585 nm and 70 kDa Texas
red labeled dextran was excited at 594 nm and the emission detected at
605–635 nm. Cell plasma membrane permeability was measured using Sytox™ deep
red using 647 nm excitation and 660–700 nm emission. Images were rendered with
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LASX (Leica Microsystems) and lysosomal ﬂuorescence was analyzed using
Volocity software (v6.3.5, Quorum).
Lysosomes in FIECs were labeled with 100 µg/ml TMR- or Alexa Fluor® 647labeled 10 kDa dextran in DMEM plus 20% FBS at 37 °C in 5% CO2. After 18 h,
FIECs were washed three times with 2 ml of prewarmed DPBS then incubated in
DMEM plus 20% FBS at 37 °C in 5% CO2 for at least 4 h prior to visualization or
experimentation to chase excess label.
LMP analysis of ﬂuorescently labeled lysosome images had their background
subtracted and noise reduced using a ﬁne ﬁlter, if necessary. Three-dimensional zplanes were merged by maximum intensity projection using Volocity (v6.3.5,
Quorum). Merged images were analyzed using Volocity Quantiﬁcation (v6.3.5,
Quorum) to detect the number of lysosomes per ﬁeld of view. The lysosomal number
in each of the channels representing the different ﬂuorophores was calculated using
intensity-based object identiﬁcation. Large-sized identiﬁed objects were excluded from
the lysosome number (>25 µm). The lysosomal count (LC) in each ﬁeld was
normalized to the LC at time 0 to generate a relative number of lysosomes (LCt0/LCt).
LMP changes for the different conditions, cell lines, C. elegans, and dextrans were
compared by analyzing the area under the curve (AUC) for each individual time series
and compared by means of one-way ANOVA analysis with Tukey multiple
comparisons using GraphPad Prism (v8.4.2; GraphPad Software, LLC).
Generation of cathepsin L knockout cell lines. Cathepsin L (CTSL) knockouts
were generated in both SW756B3-WT and SW756B3-KO using the lentiGuide-Puro
system as previously described in ref. 128. Brieﬂy, guide RNAs for cathepsin L
(TGAGGAATCCTATCCATATG) was cloned into the BsmB1 restriction enzyme
site in the lentiGuide-Puro vector (a gift from Feng Zhang; Addgene plasmid #
52963; http://n2t.net/addgene:52963; RRID:Addgene_52963). Lentivirus producing
the guide RNA and CAS9 protein from lentiCAS9-Blast (a gift from Feng Zhang;
Addgene plasmid # 52962; http://n2t.net/addgene:52962; RRID:Addgene_52962)
was made in HEK293T cells with packaging vectors psPAX2 (a gift from Didier
Trono; Addgene plasmid # 12260; http://n2t.net/addgene:12260; RRID:Addgene_12260) and pCMV-VSV-G (a gift from Bob Weinberg; Addgene
plasmid # 8454; http://n2t.net/addgene:8454; RRID:Addgene_8454). SW756B3-WT
and SW756B3-KO cells lines were transduced with the virus and cultured in
DMEM + 10% FBS under blasticidin and puromycin selection. The genomes of
these cells were then examined for indels in the CTSL gene by NGS sequencing by
the Genome Engineering and iPSC Center at the Washington University in St.
Louis, School of Medicine (Table S1), and CTSL protein levels were examined by
western blotting114.
Statistics and reproducibility. All experiments were repeated multiple (≥3
replicates unless stated) times to ensure reproducibility. For multi-well plate assays,
replicates were also contained within the plate to determine well to well variability.
Statistics were performed using either a two-tailed t-test, one-way ANOVA, or twoway ANOVA with Tukey multiple comparisons using GraphPad Prism (v8.4.2;
GraphPad Software, LLC).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
Original imaging data ﬁles can be found at https://data.mendeley.com/datasets indicated
at the end of each appropriate ﬁgure legend. Individual chart data can be found at https://
data.mendeley.com/datasets/h4n6sz9334/1. Uncropped blots and gel images can be
found as Supplementary Fig. 21.
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